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Abstract 
Although in clinical use for several decades, magnetic resonance imaging (MRI) is 
undergoing a transition from a qualitative anatomical imaging tool to a quantitative technique for 
evaluating myriad diseases. Furthermore, MRI has made great strides as a potential tool for 
molecular imaging of cellular and tissue biomarkers. Of the candidate contrast agents for 
molecular MRI, the excellent bio-compatibility and adaptability of perfluorocarbon nanoparticles 
(PFC NP) has established these agents as a potent targeted imaging agent and as a functional 
platform for non-invasive oxygen tension sensing. Direct readout and quantification of PFC NP 
can be achieved with fluorine (19F) MRI because of the unique 19F signal emanating from the 
core PFC molecules. However, the signal is usually limited by the modest accumulated 
concentrations as well as several special NMR considerations for PFC NP, which renders 19F 
MRI technically challenging in terms of detection sensitivity, scan time, and image 
reconstruction.  
In the present dissertation, some of the pertinent NMR properties of PFC NP are 
investigated and new 19F MRI techniques developed to enhance their performance and expand 
the biomedical applications of 19F MRI with PFC NP. With the use of both theoretical and 
experimental methods, we evaluated J-coupling modulation, chemical shift and paramagnetic 
relaxation enhancement of PFC molecules in PFC NP. Our unique contribution to the technical 
improvement of 19F MRI of small animal involves: (1)  development of general strategies for RF 
1H/19F coil design; (2) design of novel MR pulse sequences for 19F T1 quantification; and (3) 
optimization of imaging protocols for distinguishing and visualizing multiple PFC components 
(“multi-chromatic” 19F MRI).  
 xviii 
 
The first pre-clinical application of our novel 19F MRI techniques is blood vessel imaging 
and rapid blood oxygen tension measurement in vivo. Blood vessel anatomy and blood oxygen 
tension provide pivotal physiological information for routine diagnosis of cardiovascular disease. 
Using our novel “Blood (flow)-Enhanced-Saturation-Recovery (BESR)” sequence, we 
successfully visualized reduced flow caused by thrombosis in carotid arteries and jugular veins, 
and we quantified the oxygen tension in the cardiac ventricles of the mouse. The BESR sequence 
depicted the expected oxygenation difference between arterial and venous blood and accurately 
registered the response of blood oxygen tension to high oxygen concentration in 100% oxygen 
gas. This study demonstrated the potential application of PFC NP as a blood oxygen tension 
sensor and blood pool MR contrast agent for angiography.  
Another pre-clinical application investigated was functional kidney imaging with 19F 
MRI of circulating PFC NP. Conventional functional kidney imaging typically calls for the 
injection of small molecule contrast agents that may be nephrotoxic, which raises concerns for 
their clinical applications in patients with renal insufficiency. We demonstrated that our 19F MRI 
technique offers a promising alternative functional renal imaging approach that generates 
quantitative measurement of renal blood volume and intrarenal oxygenation. We successfully 
mapped the expected heterogeneous distribution of renal blood volume and confirmed the 
presence of an oxygenation gradient in healthy kidneys. We validated the diagnostic capability of 
19F MRI in a mouse model of acute ischemia/reperfusion kidney injury. We also employed 19F 
MRI as a tool to test the therapeutic efficacy of a new nanoparticle-based drug, i. e. PPACK (D-
phenylalanyl-L-prolyl-L-arginine chloromethyl ketone) PFC NP, which was postulated to inhibit 
microvascular coagulation during acute kidney injury. Based on our preliminary 19F MRI 
findings, we observed that PPACK PFC NP effectively reduced coagulation in our animal 
 xix
 
model, as evidenced by lesser accumulation of particles trapped by the clotting process. This 
finding suggests the potential for 19F MRI to be used as a drug monitoring tool as well in 
common medical emergencies such as acute kidney failure. 
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1 Introduction  
1.1 Quantitative molecular and functional imaging via MRI 
Magnetic Resonance Imaging (MRI) has been widely adopted as a powerful diagnostic 
imaging modality because of its superior soft tissue contrast and good safety profile compared to 
other imaging approaches that employ ionizing radiation. In last two decades, researchers have 
explored the transition of MRI from a tool for strictly anatomical depiction to a reporter of more 
complex functional and molecular information. These new imaging techniques together with so 
called “smart” contrast agents are designed to provide new disease biomarkers that identify early 
disease stages and generate quantitative diagnostic matrices for disease detection, staging, 
prognosis and therapeutic evaluation (1-3).   
Molecular imaging in particular, entails the use of functionalized targeting ligands that 
complex MR contrast agents to specific biochemical epitopes expressed on cell membranes. A 
wide variety of targeting ligands already have been synthesized and deployed as components of 
molecular contrast agent systems for noninvasive visualization of relevant biological signatures 
in cancer and cardiovascular diseases (e.g., target for fibrin (4), angiogenesis (5), growth factor 
(6) and endothelial adhesion molecule (7) et al). 
In contrast to molecular MRI, functional MRI is focused on the systematic behavior and 
physiological/pathological change of tissue and organ physiology in response to disease states or 
external stimuli. To this end, the development of MRI techniques and “functional” MR contrast 
agents might afford new opportunities for direct and noninvasive readout of essential 
physiological indexes such as diffusion (8), perfusion (9), PH (10) and blood oxygenation (11), 
among others.  
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Because molecular and functional imaging provide different but complementary windows 
into the same pathological processes, interest is growing for devising potent platforms that 
permit both molecular and functional readouts to delineate the underlying biological state of 
cancer and cardiovascular disease in a more comprehensive manner (12-13). In terms of the 
candidate contrast imaging nuclei for use with MRI, functional and molecular MRI might be 
divided into two general categories: proton and non-proton imaging. Proton imaging would take 
advantage of intrinsic or contrast-induced relaxation modulation of 1H spins, which can then 
inform about the localized expression of biological markers or alternatively reflect specific 
functional parameters revealed through the interaction of the contrast agent with important tissue 
water compartments. Non-proton MRI would be useful for directly detecting clinically relevant 
elements that exhibit net nuclear spins and could generate magnetization in an external magnetic 
field, which then interact with tissues. As the default imaging paradigm, proton MR with 
paramagnetic or superparamagnetic agents is technically translatable, but 1H based molecular 
and functional applications often suffer from omnipresent 1H background signal, which may 
hinder unambiguous identification of the expected molecular target or tissue functionality since 
the background signal is admixed and heterogeneous. In contrast, non-proton contrast MRI might 
be better suited to registering the specific presence of a disease biomarker or tissue function, 
because there might be less interfering background signal. However, as an unavoidable tradeoff, 
non-proton contrast MRI is typically more technically challenging because of the lower 
gyromagnetic ratio and the inherently lower natural abundance of relevant exogenous contrast-
producing atoms as compared to 1H spins (14).   
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1.1.1 Proton molecular and functional MRI 
The distinctive power of 1H MRI originates from the wide selection of contrast mechanisms 
that can be readily manipulated and engineered by modifying the chemistry of contrast agents, 
pulse sequences and/or imaging protocols. These contrast mechanisms might be either 
endogenous or induced by administrating extraneous contrast agents.  
Currently, there are several relevant endogenous-contrast based functional imaging 
approaches that are in or entering clinical use. Among them, diffusion weighted (tensor) MRI 
takes advantage of water diffusion in soft tissue to produce an MRI readout that  generates a 
detailed mapping of tissue microstructures that establish restricting boundaries to water diffusion 
(8). Arterial spin labeling (ASL) utilizes special pulse sequences to magnetically label arterial 
blood flow (15). It is widely studied as an alternative method to traditional perfusion imaging 
techniques, which otherwise might employ potentially nephrotoxic contrast agents. Blood-
Oxygenation-Level-Dependent (BOLD) MRI permits non-invasive detection of neural activation 
and metabolism by measuring T2* contrast generated by deoxygenated hemoglobin (11).  
Exogenous contrast agents are usually engineered for specific applications and exhibit well 
characterized biochemical properties. The contrast mechanisms of 1H functional and molecular 
imaging usually entails one of several approaches to modulate local relaxation. 
Superparamagnetic iron oxide (SPIO) particles generate local magnetic field inhomogeneities 
that can be visualized using T2*-weighted gradient echo sequences (16). Paramagnetic contrast 
agents such as Gd and Mn affect proton relaxation in proportion to their absolute concentration, 
which can be represented by the signal intensity of T1-weighted images (17). Several other 
contrast mechanisms (such as T1ρ (18) and CEST (19)) are intriguing but eventual clinical 
adoption of these methods remains under investigation. However, for purposes of molecular 
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imaging, it is clear that all 1H based imaging techniques would require an extra scan to acquire a 
pre-contrast baseline view since only relative changes in signal are examined upon contrast 
localization, making these approaches highly susceptible to position shifts between the two 
scans, which poses difficulties for fiducial image coregistration. 
1.1.2 Non-proton molecular and functional MRI 
In addition to protons, other nuclei exhibit net nuclear spins. Most of these nuclei (e.g., 31P 
and 23Na) have much lower gyromagnetic ratios (31P: 108.4µ106 rad∏s-1∏T-1, 23Na: 70.8µ106 
rad∏s-1∏T-1) and therefore dramatically different resonant frequencies from 1H (267.5µ106 rad∏s-
1
∏T-1). Despite their relatively low MR sensitivity, 31P and 23Na are widely exploited as 
endogenous non-proton nuclei for functional imaging of tissue metabolism because they are key 
elements of important organic and inorganic molecules that are naturally present in animals and 
humans (20-21).  
With respect to our interest in fluorinated agents for imaging that will be examined in depth 
in this thesis, the gyromagnetic ratio of the 19F nuclear spin (251.8µ106 rad∏s-1∏T-1) is very close 
to that of 1H. Because the MRI signal is proportional to the gyromagnetic ratio, at similar 
concentration levels 19F spins can generate comparable MR signals to those for 1H spins, both 
being much stronger than that of other MR-active imaging nuclei. Moreover, because there is no 
19F background in human body (and animals) under physiological conditions, 19F imaging can be 
performed without the need for a pre-scan. This unique feature of 19F MRI renders it a promising 
imaging approach with extraordinary specificity. Finally, because 19F atoms can be readily 
engineered into various organic molecules by substituting 1H, 19F MRI with the use of 
appropriately functionalized contrast agents represents a versatile molecular imaging paradigm 
for quantifying biomarker expression at the cellular and tissue level (22). 
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1.2  Perfluorocarbon nanoparticle as a MRI contrast agent 
Perfluorocarbon (PFC) based nanoparticles (NPs) are a class of highly adaptable delivery 
vehicles for targeted molecular imaging and a functional platform for noninvasive oxygen 
tension (pO2) sensing. PFC comprises 19F-containing molecules that are derived from 
hydrocarbons by substitution of 1H with 19F atoms. The PFC component has been clinically 
approved as blood substitute for over 20 years and exhibits a good bio-safety profile because it is 
biologically inert and not metabolized in vivo. The nominal size of a PFC NP is 200-250 nm in 
diameter and the half life in the blood stream is 2-4 hours. The particles are cleared predominatly 
by the liver and spleen and the PFC components are vaporized through the lung. In addition to 
applications in diagnostic imaging, PFC NPs also have been developed as a potential vehicle for 
drug delivery (23-26). 
PFC NP formulation consists of a hydrophobic core of PFC molecules encapsulated within a 
phospholipid surfactant monolayer coating. A variety of PFC compositions can be used to form 
the PFC core based on a generalized synthetic procedure. Conventional 1H imaging contrast 
agent (such as Gd chelates), fluorescence imaging moieties, drugs, and important targeting 
ligands can be conjugated covalently or noncovalently to the surface of the lipid layer to 
functionalize the PFC NPs. Therefore, PFC NPs serve as excellent candidates for molecular and 
functional imaging of both 1H and 19F MRI, although in this dissertation we will focus on 
examining applications of PFC NP for 19F MRI. 
1.2.1 Targeted molecular imaging using 19F MRI of PFC NP 
Targeted PFC NPs actively bind to molecular biomarkers at disease sites and can be imaged 
with the use of 19F MRI. It has been shown that 19F MRI can report sparse distributions of PFC 
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NP even at very low concentrations (i.e., picomolar nanoparticle levels) (27). As compared to 
imaging PFC NP that incorporate Gd atoms as a contrast agent, when imaging the fluorine core 
elements with 19F MRI one can avoid potential renal damage or nephrogenic systemic fibrosis 
that can be attributed to the systemic toxicity of the lanthanide components (28).  
Applications of molecular 19F MRI have been demonstrated in multiple preclinical animal 
models simulating either cardiovascular disease or cancer in human. For example, tumor 
angiogenesis could be successfully depicted by 19F MRI of αvβ3 integrin targeted PFC NP (29). 
The same particle containing fibrin targeting ligands binds to unstable or disrupted 
atherosclerotic plaques where rupture exposes the arterial wall to clot formation. In this 
particular application, 19F MRI offers a quantitative readout of local particle concentration and 
confirms the expected heterogeneous accumulation of PFC NPs throughout the vascular wall 
(30). Moreover, in cases of very advanced plaques with endothelial barrier disruption, PFC NP 
without any targeting ligands passively penetrate into these plaques to reveal highly permeable 
and disrupted lesions that might portend eventual heart attack or stroke (31). Furthermore, 
advanced MR pulse sequences (e.g., diffusion weighted 19F sequence (32)) in association with 
other targeting moieties (e.g., adhesion molecules such as vascular cell adhesion molecule, or 
VCAM (7)) may extend 19F molecular imaging to early detection of inflammatory vascular 
disease.  
1.2.2 Cell tracking using 19F MRI of PFC NP 
Another important application of PFC NP for19F imaging is cell tracking. Multiple cells types 
can be labeled with PFC NP for in vivo tracking after injection as tissue regenerative therapies in 
preclinical models, e.g., heart ischemia (33), lung injury (34) and organ transplant (35), among 
others. Among all cell types, the macrophage is the most widely studied because of its critical 
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role in vascular inflammatory processes. Macrophages can be labeled with PFC NP either 
through in vitro incubation or in vivo labeling in blood stream. Macrophages internalize PFC 
NPs through endocytosis and then actively home to the disease regions without any observable 
loss of cellular functionality. 19F MRI enables a noninvasive measurement of the macrophages 
recruitment, which is an essential component of plaque inflammation (36). In addition to 
macrophages, various stem cells (37) and immune dendritic cells (38) have been labeled with 
PFC NP. Accordingly, in vivo tracking of stem cells labeled with unique, no background fluorine 
signatures could provide a useful imaging approach for monitoring on-going trials of stem-cell 
therapy.  
1.2.3 PFC NP as an oxygen sensor 
Because of the long residence time (2-3 hours) in blood stream, PFC NP can be employed as 
a blood pool contrast agent in near steady state conditions. Conventional study of neat PFC 
molecule has revealed that the relaxation time of 19F (or, R1 = 1/T1) is linearly correlated with 
local oxygen tension. In these studies, PFC was administrated directly into solid tumors followed 
by 19F T1 measurement to generate oxygenation mapping. It has been demonstrated in previous 
reports that 19F MRI of PFC NP was more sensitive to detect tumor hypoxia as compared with 
conventional BOLD MRI (39). 
Functional 19F imaging with PFC NP also has been validated in other organs. For example, 
19F MRI of PFC NP has been utilized as a non-invasive method to evaluate oxygen tension in 
livers and spleens, because most PFC NPs are trapped by reticuloendothelial system after being 
cleared from the blood stream (40). As another interesting application of functional imaging with 
PFC NP, Duong et al proposed a new method for measuring arterial and venous blood fraction in 
mouse brain (41) by combining absolute quantification of 19F concentration and 19F T1. 
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1.2.4 PFC NP as a 1H molecular imaging contrast agent 
Applications of PFC NP containing large quantities of Gd (100-200,000 atoms as chelates) 
for use as a 1H contrast agent for molecular imaging have been extensively investigated in 
preclinical models of cancer and cardiovascular disease, among which angiogenesis imaging 
appears most promising (42). In this case, targeting the PFC NP to the αvβ3 integrin, which is 
present in large quantities on newly forming blood vessels in cancers and atherosclerosis, 
facilitates active binding to locations where new blood vessels are sprouting. Because the Gd 
payload is situated on the surface of PFC NP, a direct inner-sphere dipole-dipole interaction 
occurs between Gd and the water molecules in the vicinity of the αvβ3-integrin targeted sites. The 
magnitude of the relaxation effect is dependent on the chemical structure of the Gd chelates, and 
those chelates with very short lipid linker segments (Bis-oleate-DTPA) that partially hide the Gd 
at the particle surface manifest lesser effects than do those with longer lipid linker chain (e.g., 
DOTA-DPPE) that allow more flexible exposure to surrounding waters. (43). Conventional T1-
weighted spin echo or gradient echo sequences can be employed to visualize accumulation of 
particles in vivo. Other combinations of targeting ligands (e.g., α5β1 (44) and Robo4 (45)) and 
imaging agents on PFC NP (e.g Mn (46)) have been formulated and validated in preclinical 
disease models. 
  
1.3 Technical challenges of 19F MRI 
Although 19F MRI of PFC NP has undergone rapid growth in last 10 years and presents a 
promising future for eventual deployment in clinical settings, this new imaging paradigm is still 
in its early technical development stages and will benefit from further technical advances to 
bridge the gap between laboratory investigations and clinical utility. Compared to 1H MRI, 19F 
 9
 
manifests no appreciable background signal, and so the signal strength for 19F MRI is limited by 
the modest doses of fluorine that can be administered as PFC NP. Therefore, it is critical to 
improve imaging methodologies to enhance the detection limits for PFC NP that typically are 
present in low concentrations. Moreover, accurate quantification of PFC NP in vivo requires 
robust imaging methods immune to potential field inhomogeneities associated with the imaging 
system (B0, B1 and sensitivity), because the spatial distribution of PFC NP for molecular 
imaging is generally heterogeneous, as a consequence of the individual expression patterns of the 
targeted pathological epitopes, which are typically sparse in tissue. Finally, in contrast to 1H 
atoms in water, 19F atoms in PFC experience a more complicated chemical environment, which 
might result in multiple chemical shifts and scalar coupling (J-coupling) between different 
groups, all of which complicates the imaging objective.  
1.3.1 Signal to Noise Ratio (SNR) 
There are two major factors limiting the potential MR signal strength for 19F MRI: one is the 
total number of 19F nuclei present in the targeted tissue and the other is the Boltzmann 
distribution which leaves only a small portion of all the 19F nuclei generating observable 
magnetization. Several approaches have been pursued to improve SNR in 19F MRI. It is well 
accepted that improving the sensitivity of 19F RF coils is the most straightforward approach to 
increase image quality. It is necessary to design application-specific RF coils which are suitable 
to particular imaging animals and organs and thus avoid RF loss on redundant components (low 
filling factor) of the RF coils. Moreover, improving electronic design of RF coils and enhancing 
the quality factor (Q value) of RF circuits might also substantially improve the receive 
sensitivity. Besides RF coils, pulse sequences also are targets for optimizing 19F imaging. It has 
been shown that different pulse sequences might yield over 3-fold better SNR for the same 
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imaging subject (47). Therefore, it is essential to design or choose appropriate pulse sequences 
that are suitable for specific 19F imaging applications. Recently, researchers have reported 
several pioneering trials to develop hyperpolarization technique for 19F spins (48). Theoretically, 
by hyperpolarizing 19F spins, 19F spins could break the thermal equilibrium state (Boltzmann 
distribution) and produce several orders of magnitude stronger MR signals.  
1.3.2 Quantitative methodology 
19F MRI is quantitative in principle because 19F spin density is linearly correlated to the PFC 
NP concentration and 19F relaxation directly reflects oxygenation. However, in most in vivo 
applications, many other factors might come into play and affect the measurement accuracy of 
19F MRI. For example, 19F quantification might suffer from field inhomogeneity of the transmit 
and receive coils. Moreover, the measured 19F signal might not only reflect 19F concentration but 
be convoluted with other factors that might induce changes of 19F T1 and T2 et al. Similar to 1H 
MRI, 19F also is susceptible to imaging artifacts, such as motion and eddy current artifacts, all of 
which compromise image quality and generate unexpected errors for quantification (29). 
Therefore, in order to achieve reliable and reproducible 19F MRI measurements across different 
applications, it is necessary to implement robust correction methods and optimized artifact-
resistant pulse sequences.  
1.3.3 J-coupling and chemical shift 
PFC molecules are more complicated than water in terms of their NMR properties. PFC can 
exhibit multiple chemical shifts, and 19F atoms from different chemical groups can also have 
strong interactions with each other. Therefore, imaging 19F spins in PFC molecule can be more 
challenging than is 1H imaging. For example, chemical shifts might cause shift artifacts along the 
readout gradient direction, and special reconstruction algorithms are needed to correct for these. 
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Moreover, J-coupling between different chemical groups in PFC molecule causes “T2-shortening 
like” behavior in spin echo-based MRI, i.e., J-modulation, which significantly reduces the 
detectable signal intensity for 19F imaging. However, once the underlying physics of these 
special NMR features of PFC NP are accounted for, we can avoid the resultant artifacts or even 
take advantage of these properties and expand 19F MRI to additional applications (49). 
  
1.4 Dissertation objective and organization 
1.4.1 Overarching objective 
The objectives of this dissertation are three fold. (1) We aimed to understand the physical and 
chemical properties of PFC NP that are related to its applications as a 19F MRI contrast agent. 
We will build up physical models that apply quantum mechanical principles to investigate the 
spin dynamics of 19F nuclear spins in an external magnetic field, and to examine the interaction 
between 19F spins and other nuclear spins and electron spins. (2) Based on the theoretical frame 
work of 19F spin dynamics and MRI engineering, we seek to implement novel MRI imaging 
techniques including pulse sequences, RF coils, imaging protocols and chemical modifications to 
enhance and expand the use of PFC NP-based functional and molecular 19F MRI in preclinical 
animal models. (3) With the newly developed 19F MRI techniques, we will devise and validate 
new biomedical applications of 19F functional MRI in small animal models. These applications 
include a novel 19F MRI based rapid blood oxygenation measurement method and a new 
comprehensive diagnostic approach for evaluating kidney endothelial damage based on 19F MRI 
of circulating PFC NP. We anticipate that these preclinical studies should demonstrate the 
superior diagnostic capability of 19F MRI and can be readily translated to real world clinical 
applications.  
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1.4.2 Organization 
Following the introduction, in Chapter 2, we present a general coupled resonator model and 
validate this model as a universal strategy for building 1H/19F dual frequency RF coils. We also 
summarize and investigate the general requirements for designing transmit and receive coils for 
19F MRI and validate our methods in phantom and in vivo studies. This chapter has been 
published in Journal of Magnetic Resonance Imaging, Volume 34, Issue 1, pages 245–252, July 
2011 
In Chapter 3, we establish physical models and propose theoretical treatments for the NMR 
properties of PFC NP. We investigate the effect of oxygenation on the absolute quantification of 
PFC concentration in vivo and in phantoms. In this part, we propose general criteria for 
achieving consistent and highly sensitive PFC quantification that is robust against oxygenation 
effects on relaxivity. Using a density matrix calculation and Hamiltonian time-evolution, we 
investigate theoretically the J-coupling induced amplitude modulation effect in PFC NP and 
develop a method to suppress the potential imaging artifacts associated with this effect. In the 
end, we study the chemical shift effect of PFC NP, from which we propose a “multi-chromatic” 
19F MRI technique for selectively imaging of multiple PFC NPs separately in the same imaging 
subject. 
In Chapter 4, we examine the interaction between 19F spins inside PFC NP with 
paramagnetic ions on the surface or in the surrounding solution. In this part, the paramagnetic 
relaxation enhancement effect of Gd on 19F is calculated theoretically with the use of quantum 
perturbation theory. We observe that short-linker paramagnetic chelates that are covalently 
conjugated to the surface of PFC NP may significantly enhance 19F relaxation and this effect is 
modulated by cellular endocytosis and particle lipid breakdown mechanisms in endosomes as a 
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probe of cellular activation. This chapter has been published in Journal of Magnetic Resonance 
Imaging, Volume 34, Issue 3, pages 653–661, September 2011 
In Chapter 5, we exploit PFC NP as a blood pool contrast agent for angiography and blood 
oxygenation sensing. We demonstrate the application of PFC NP as a blood oxygen tension 
probe with the use of a novel blood-flow enhanced saturation recovery (BESR) pulse sequence. 
Compared to the traditional Look-Locker sequence, the BESR sequence is insensitive to B1 and 
B0 field inhomogeneity and pulsatile blood in-flow effects. Compared to traditional invasive 
measurements using cardiac catheterization, the BESR sequence provides a simple and rapid 
method for non-invasive assessment of blood oxygenation in vivo.  This chapter has been 
published in Magnetic Resonance in Medicine, DOI: 10.1002/mrm.24436. 
In Chapter 6, we develop a new 19F functional MRI technique for kidney imaging. We first 
validate the feasibility and durability of our technique for measuring renal blood volume and 
intrarenal oxygenation in healthy kidneys. The measured regional intrarenal blood volume and 
oxygenation appears to be consistent with prior experimental observations. In a mouse model of 
ischemia-reperfusion acute injury, 19F MRI of PFC NP is shown to delineate reduced blood 
volume at cortico-medullary junction and vascular leakage at medulla as a consequence of 
endothelial damage. Finally using 19F MRI as a treatment evaluation tool, we confirm the 
treatment effect of a novel PFC NP based anti-clotting drug for inhibiting intrarenal coagulation 
during acute kidney injury. This chapter is under revision for Magnetic Resonance in Medicine. 
In the last Chapter, we summarize these findings throughout the dissertation, and discuss 
future work for PFC NP based functional and molecular 19F MRI. 
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2 General strategy for building 1H/19F RF coils 
2.1 Background 
Dual-nuclei 19F/1H MRI/MRS is emerging as a novel imaging technique for molecular 
imaging and quantification of tissue pathology that features both rapid acquisition with high 
spatial and temporal resolution (1H) and unique, no background spectral signatures (19F) (1). 
However, MRI of fluorinated contrast agent suffers principally from low sensitivity especially at 
clinical field strengths, even despite the fact that 19F is a high signal nucleus, requiring 
millimolar quantities of contrast agent per voxel for detection (2). Because the amount of 
fluorine achievable by molecular targeting is limited by the concentration of epitopes that bind 
the contrast agent, which itself is a function of the tissue pathobiology, improvements in 
sensitivity and speed are better addressed with the use of specialized and dedicated RF coils. 
Such coils could be designed to simultaneously achieve high signal-to-noise ratio (SNR) and 
homogeneous acquisition for detecting and quantifying molecular biomarkers with dual-nuclei 
19F/1H MRI. 
Previous studies typically used single-frequency mode RF coils for 19 F/1H MRI. A common 
approach is to use frequency tunable coils, in which case the coil must be tuned to either 19F or 
1H frequency to maximize SNR at the cost of extra time for coil tuning and positional shifting of 
the imaged object (3). Alternatively, a two-coil setup with a volume coil for 1H imaging and 
surface coil for 19F imaging introduces inherent sensitivity profile differences at the two 
frequencies (4).  Finally, the usage of auto-tuned RF coils that can switch resonant frequency 
with the assistance of an external computer program entails extra complexity and the associated 
higher cost of the imaging system (5). Thus, the use of single-frequency mode RF coils for 
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19F/1H MRI imaging poses a number of limitations including challenges in simultaneously 
achieving high sensitivity and B1 field homogeneity, and inaccurate co-registration of 1H/19F 
signals due to positional artifacts caused by coil retuning (6). It has been shown that these 
limitations may be minimized with the use of dual-frequency mode RF coils for multi-nuclear 
MRI/MRS (7).  
Regarding the details of coil design, the commonly used shunting method and multiple poles 
method for designing dual-frequency coils work well when the two resonant frequencies are well 
separated, e.g., for 1H (42.58 MHz/T) and 13C (10.71 MHz/T). However, such methods are not 
well suited for designing 19F/1H MRI coils (8-9) because the gyromagnetic ratio of 19F (40.08 
MHz/T) is close to that of 1H (10). Several dual-frequency strategies have been proposed for 
MRI/MRS at close frequencies but each has limitations. A universal matching circuit for multi-
nuclei NMR has been proposed (11), but it requires multi-port inputs for multi-frequency. 
Alternatively, several dual-frequency strategies for close and well-separated frequencies have 
been proposed based on the special resonant property of a birdcage resonator (12-14). In these 
works, the two crossed cages or two different modes of a birdcage are utilized to achieve the 
double resonance, so these techniques are only suitable for coils with birdcage geometry, and 
could lead to different B1 field distributions at the two frequencies. Recently, a novel 19F/1H 
dual-frequency solenoid coil with identical field distribution at two frequencies at 3 T has been 
proposed by researchers at Philips Research based on the coupled resonator model (15). 
However, it remains unknown whether this concept establishes a general RF design approach for 
such RF coils considering the various geometrical and electrical parameters required to fit the 
needs of diverse experimental situations (16).  
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In the present work we seek to develop the coupled resonator model as a universal technique 
to design and fabricate 19F/1H dual-frequency coils in diverse configurations. Due to the different 
impedances at the two resonant frequencies, matching for a dual-frequency coil remains a critical 
challenge in practical application. Accordingly, the electrical properties of the coupled resonator 
model were considered and a numerical calculation was executed to prove that a series capacitive 
matching network is theoretically effective in matching the coupled resonator to 50 Ohm at both 
19F and 1H frequencies (9,17). A 19F/1H dual-frequency birdcage RF coil for in vivo imaging at 
4.7 T was implemented to illustrate the feasibility of the model. Finally, for an experiment 
requiring high imaging SNR within a short acquisition time, an actively-decoupled 19F/1H dual-
frequency saddle coil was built. We show that using the saddle coil for 19F  and 1H excitation and 
using an actively-decoupled surface coil on 19F frequency for both 19F and 1H signal receiving, 
the two-coil setup can achieve homogeneous excitation with high sensitivity for 19F MRI while 
retaining sufficient SNR from 1H signal for anatomy images.   
 
2.2 Material and Methods 
2.2.1 Coupled resonator model 
In the present coupled resonator model, the RF sample coil is connected to a secondary 
inductor and capacitor (LC) resonator with a coupling capacitor in series (Figure 2.1a). For 
nuclei with close resonance frequencies, such as 1H and 19F, the inductance of a MR sample coil 
can be treated as a constant value. Following the theoretical analysis proposed by Haase et al 
(18), when the secondary resonator is built with identical frequency to the sample coil, two 
possible oscillating modes are formed within the circuit, namely in-phase and anti-phase modes. 
When resonating at the in-phase mode, the two resonators of the circuit have equal electrical 
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potentials, and thus the voltage and current across the coupling capacitor always remains zero. In 
this case, the coupling capacitor can be virtually removed and then the equivalent circuit of the 
coupled resonator can be drawn as Figure 2.1b with the resonant frequency  
11/hi H tB LCω γ= = .  [1] 
In contrast, for the anti-phase mode, the electric potential at both sides of the coupling capacitor 
is opposite, so the voltage at the middle point of coupling capacitor remains zero. For circuit 
analysis, a virtual short wire can be added between the ground and the middle point of the 
coupling capacitor (Figure 2.1c), and thus it gives rise to a different resonant frequency 
11/ ( 2 )lo F t cB L C Cω γ= = + .        [2] 
Given the gyromagnetic ratios of 1H and 19F, when 
1/ 0.064c tC C = ,                     [3] 
the two frequencies of the coupled resonator correspond to 1H and 19F frequencies, in agreement 
with the analytic calculation of transfer impedance (19).  
2.2.2 Impedance matching  
Impedance matching is critical in dual-frequency coil design, because the circuit impedance 
could be different at the two resonant frequencies. For the coupled identical resonator model 
(Figure 2.1d), specifically, by inverting the admittance of the parallel components, the 
impedance of the coupled resonator is  
1
1
1 ( )
t
L
hi
L C
X rZ
X r X
+
=
+ +
         [4] 
at high frequency or in-phase mode; and  
1
1
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at low frequency or anti-phase mode. 
In the proposed dual-frequency coil design (Figure 2.1d), the coupled resonator is 
connected to the MR scanner at the end of the secondary resonator in series with a capacitor 
matching circuit. In this case, a small detuning of two resonators, which renders them slightly 
off-resonance, is able to introduce an extra degree of freedom and compensate for the impedance 
difference (18). To show the coupled resonator can always be matched to 50 Ohm with the use of 
appropriate values for tuning, coupling and matching capacitors, we numerically calculated 
several realistic circuit examples corresponding to various combinations of internal resistances of 
the sample coil and secondary resonator. With no loss of generality, we assumed that the sample 
coil with an inductance 32 nH, which is equal to the inductance of the secondary resonator, is 
designed to work at 4.7 T for dual-frequency 19F and 1H imaging. A custom-developed program 
in Mathematica (Wolfram, USA) was used to seek for the appropriate values of 1tC , 2tC , cC , 
and mC  to match the circuit at both frequencies (188 MHz and 200 MHz). In the program, the 
preset values of 1tC , 2tC , cC  were first calculated according to Eqs. 1-3; then mC  was set to be 
a qualitatively correct value according to Eqs. 4-5; finally, a nonlinear root-seeking algorithm 
was carried out to vary all the capacitances around their preset values to successively achieve 
impedance matching.  
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Figure 2.1 Schematic diagram of a coupled resonator circuit. (a) the resonator formed by 
capacitor 2tC  and probe (with inductance L ) is capacitively coupled, by capacitor cC , to the 
secondary resonator formed by capacitor 1tC  and inductor L . (b & c) the equivalent circuit of 
in-phase and anti-phase mode. (d) coupled resonator is capacitively matched to 50 Ohm with mC
. 
2.2.3 Implementation of two typical designs of volume coils for 1H/19F MRI at 4.7 T 
To prove the general application of the concept, two typical designs of 19F/1H volume coils 
were implemented. The first design was a transmit/receive birdcage coil for the whole body 
imaging and the second design was an actively-decoupled saddle coil that can be used with other 
actively-decoupled 19F surface coils for high resolution cardiovascular imaging. Both coils were 
designed to work on a Varian 4.7 T small animal scanner, with 19F and 1H resonant frequencies 
of 188 MHz and 200 MHz, respectively.  
The high-pass 8-leg birdcage coil (Figure 2.2a) was built with adhesive copper tape on an 
acrylic tube of 50 mm diameter and 128 mm length. The whole coil was placed in a copper 
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shield with a diameter 135 mm and then the 1st resonant mode of the birdcage coil was tuned to 
200 MHz (20). The secondary resonator was built with a tunable capacitor in parallel with a 
custom-made inductor, which has a diameter of 4 mm and the same inductance with the sample 
coil. The secondary resonator was positioned >5 cm away from the sample coil to minimize 
inductive coupling between two circuits. The coupling between the sample coil and secondary 
resonators was implemented with another tunable capacitor in series with a fixed value capacitor 
on the other port for the purpose of balancing. The secondary loop also was tuned to resonance at 
200 MHz. The value of coupling capacitor was then adjusted to over-couple these two resonators 
giving rise to the second distinct frequency at 188 MHz (20). The feed point for this coil was 
located at the secondary resonator input and the whole circuit was matched to 50 Ohm with a 
tunable capacitor and fixed value capacitor. 
The actively-decoupled saddle coil (Figure 2.2b) was made with adhesive copper tape on an 
acrylic tube of 70 mm diameter and 40 mm length. Four fixed value capacitors were evenly 
distributed along the coil to maintain the constant current distribution within the coil. The end of 
the coil was connected to fixed value capacitors in parallel with a variable capacitor. The 
secondary resonator was built with a custom made inductor in parallel with a fixed value 
capacitor and variable capacitor. The coupling and matching circuit configuration was the same 
as the dual-frequency birdcage and uses variable capacitors in series with fixed value capacitors.  
The actively decoupling method for the saddle coil was the same as mentioned in previous study 
(9). In order to enable the decoupling switching circuit to be compatible with the dual-frequency 
circuit, an RF choke (RFC) and PIN diode were inserted in the leg of the sample coil and 
controlled by a separate coaxial cable.    
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Figure 2.2 RF coil circuits and evaluation.  (a) dual-frequency transmit/receive high-pass 
birdcage coil for 4.7 T. (b) dual-frequency actively-decoupled saddle coil for 4.7 T. (c) S11 of 
dual-frequency birdcage coil. (d) S11 of actively-decoupled dual-frequency saddle coil when 
switched on and off.   
2.2.4 Bench test of electromagnetic performance 
Laboratory bench tests were performed on a network analyzer (Hewlett Packard 8751A). For 
the tuning and matching procedure, there are a total of four variable capacitors to be adjusted for 
each coil. Tuning capacitors for the sample coil and secondary resonator were first adjusted to 
tune the two resonators to essentially the 1H frequency. Then the coupling and matching 
capacitors were adjusted to achieve the second frequency at 188 MHz, followed by matching the 
dual-frequency coil impedance to 50 Ohm.  The coil return loss (S11) of two coils was by using a 
50 ml tube filled with saline to mimic the electrical load of a live mouse. The quality factors (Q) 
were measured from S11  as described in (9).  S21 measurement of the B1 fields produced by the 
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sample coils was performed with a 10 mm shielded loop for signal pick up. For the actively-
decoupled saddle coil, transmission properties were measured when the coil was switched to 
“on” and “off” state, respectively.  
2.2.5 Phantom and in vivo imaging  
A 1H image of a 50 ml tube was acquired with the dual-frequency birdcage coil or actively-
decoupled coil pair (with dual-frequency transmit saddle coil and single-frequency 19F surface 
coil), respectively. Image acquisition parameters were: pulse sequence, gradient echo; TR, 20 
ms; TE, 4 ms; number of average, 1; in plane resolution: 0.4 mm * 0.4 mm; slice thickness, 0.2 
mm. Normalized intensity profile was calculated along the axial direction of acquired images.  
To evaluate the induced signal loss in the secondary resonator, we compared the SNR of the 
same phantom by setting the coil under single and double-frequency modes. Specifically, the 
actively-decoupled circuit of the saddle coil was manually shorted to operate the coil in 
transmit/receive mode. The single-frequency mode was achieved by removing the secondary 
resonator circuit. A 50 ml tube filled with saline and 10% perfluoro-15-crown-5-ether (CE) 
emulsion was imaged with a gradient echo sequence. The formulated CE emulsion is composed 
of 20% (or 40%) (v/v) of CE (Exfluor Research Corp., USA), 2.0% (w/v) of a surfactant 
commixture, and 1.7% (w/v) glycerin, with water comprising the balance (21).  
The imaging quality with the transmit/receive dual-frequency birdcage coil was evaluated for 
whole body mouse 19F imaging on the Varian 4.7 T small animal scanner. A C57Bl/6 mouse was 
anesthetized with a standard dose of ketamine/xylazine followed by intravenous injection of 
4ml/kg CE emulsion (20% v/v). Multi-slice axial 1H and 19F images of the mouse body were 
acquired. 19F MRI parameters were: pulse sequence, gradient echo; TR, 40 ms; TE, 4 ms; 
number of average, 1024; in plane resolution, 1.8 mm * 1.8 mm; slice thickness, 10 mm. 
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The efficiency of the actively-decoupled dual-frequency saddle transmit coil was 
demonstrated by 19F angiography in a mouse (22). An actively-decoupled 19F surface coil was 
used for receiving. Specifically, a Swiss Webster mouse was anesthetized with 
ketamine/xylazine as above followed by intravenous injection of 40% v/v perfluoro-15-crown-5-
ether (CE) NP (5ml/kg). 2D time-of-flight and whole projection gradient echo sequences were 
used to acquire the 1H and 19F image of blood vessel in the neck, respectively (23).  1H/19F 
imaging parameters were: TR, 80 ms; TE, 4 ms; number of average, 4 for 1H imaging and 512 
for 19F imaging; voxel resolution, 0.27 mm*0.27 mm*0.4 mm for 1H imaging and 0.8 mm*0.4 
mm*10 mm for 19F imaging; 90 degree pulse width at 45 dB RF output power, 280 µs for 1H and 
310 µs for 19F.  
 
2.3 Results 
Photographs of dual-frequency 1H/19F volume coil, the associated surface receive coil and the 
4.7 T small animal MRI scanner that that was employed in this study are shown in Figure 2.3. 
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Figure 2.3 Photographs of RF coils and 4.7 T small animal scanner. (a) Double-tuned high pass 
birdcage coil of 50 mm in diameter placed in a copper shield with a diameter of 135mm. (b) 
Active decoupling surface coil as a possible choice as receiving probe. (c)  Geometric and active 
decoupling were utilized to reduce the interference between two coils. (d) Probes were tested on 
Varian 4.7-Tesla ANOVA console.  
2.3.1 Numerical calculation of impedance matching  
Numerical solutions for the tunable capacitors to optimize impedance matching were 
obtained using the root-seeking program. For various combinations of internal resistances of the 
sample coil and secondary resonator, the calculated relative capacitances are listed in Table 1. 
Although the numerical results exhibited small variations (<3 pF) from the analytic solutions of 
the ideal coupled resonator model, they were found to closely approximate the preset analytic 
values, indicating that the fundamental physical features of the coupled resonator are represented 
in a realistic coil design.  
Table 1 Nonlinear Root-Seeking of Capacitance Values for Impedance Matching 
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2.3.2 Tuning, matching, and sensitivity profile 
Figure 2.2c&d depict the S11 of two dual-frequency coils at their working frequencies.  All 
coils achieved impedance matching at both 1H and 19F frequencies. When the PIN diode was 
switched on, the saddle coil was detuned from both 1H and 19F frequencies. The unloaded Q 
values for birdcage and saddle coils were 200 and 144 at 1H frequency; 106 and 95 at 19F 
frequency. The loaded Q values for birdcage and saddle coils were 58 and 66 at 1H frequency; 80 
and 84 at 19F frequency. Figure 2.4 shows the B1 field distribution, measured from 
corresponding coupling intensity in S21, of the birdcage coil and saddle coil working at both 19F 
and 1H frequencies. For the birdcage coil, the fluctuation of magnetic field strength was less than 
10% for > 60% area in radial direction and > 75% of area in axial direction (Figure 2.4a&b). 
When the saddle coil was switched on, the fluctuation of magnetic field strength was less than 
10% for > 50% area in radial direction and > 50% area in axial direction (Figure 2.4c&d). 
Because the switch segment for actively-decoupling was inserted into the leg of the sample coil, 
when the sample coil was switched off the secondary resonator remains on frequency (Figure 
2.2d) but does not produce any observable magnetic field in the region of interest (Figure 
2.4c&d).   
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Figure 2.4 B1 field profiles of dual frequency RF coils. (a & b) normalized B1 field along the 
diameter and axis of the dual-frequency birdcage coil. (c & d) normalized B1 field along the 
diameter and axis of the actively-decoupled dual-frequency saddle coil when switched on and 
off. 
2.3.3 1H/19F imaging 
The 90± pulse width of the single-frequency version of the saddle coil was 230/250 µs for 
1H/19F frequencies. In comparison, the 90± pulse width of the dual-frequency version of the 
saddle coil was 300/310 µs for 1H/19F frequencies. Good homogeneity can be visually 
appreciated from the image intensity profile of phantom images , although dual-frequency circuit 
caused 50% and 25% loss of image SNR for 1H and 19F (Figure 2.5a-c). High sensitivity 
(SNR>10) was observed for the in vivo 1H and 19F imaging within the field of view (Figure 2.5d-
f). The two imaging slices from the mouse body acquired with the dual-frequency birdcage coil 
show a high level of 19F signal in the liver and heart (Figure 2.5d&e), reflecting the 19F signal of 
 34
 
CE NP in the liver and the ventricular blood-pool. Figure 2.5f shows a coronal slice of “maximal 
intensity projection” of the 1H and 19F angiograms, wherein blood vessel geometry can be 
evaluated clearly. Note that the voxel size for 19F imaging is greater than the diameter of mouse 
blood vessels; in this case larger blood vessels (jugular veins) would yield a stronger signal in a 
single voxel due to partial volume effects.  
 
2.4 Discussion 
Impedance matching at both frequencies is achieved by incorporating appropriate degrees of 
freedom (number of independent variable capacitors) within the circuit, despite the added 
complexity of calculating an analytical solution from the ideal coupled resonator model. 
Specifically, the impedance matching at two separate frequencies embeds two equations in the 
complex number domain or four equations in the real number domain. Thus, four independently 
tunable capacitors are sufficient to guarantee the existence of solutions for a good matching.  
It is worth mentioning that the matched quality factor (Q) measured from S11 does not 
necessarily provide a useful measurement for a dual-frequency RF coil based on the coupled 
resonator. The Q value of the coil is affected by losses associated with the sample coil and the 
secondary LC circuit (9). In this case, alternative metrics can be exploited to assess the 
performance of the dual-frequency coil, e.g., imaging sensitivity test and measurement of the 
pulse width with given power and flip angle. 
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Figure 2.5 Phantom and in vivo test of RF coils. Sensitivity profile of proton images of a 50 ml 
tube filled with saline acquired with dual-frequency birdcage coil (a) and a single tuned surface 
receive coil in conjugation with an actively-decoupled dual-frequency saddle transmission coil 
(b). (c) comparison of imaging quality of single-frequency and dual-frequency versions of the 
same saddle coil. 1H and 19F images acquired with dual-frequency birdcage coil show the PFC 
signal in liver (d) and cardiac blood pool (e). (f) 1H and 19F angiography show the carotid artery 
and jugular vein images. Image SNR was calculated by averaging SNR in manually selected 
region of interest. 
For certain cases of imaging of fluorinated contrast agents, which requires an extensive field 
of view for the 1H imaging portion, the actively-decoupled saddle coil can be used as a transmit 
coil for 19F imaging, and as a transmit/receive coil for 1H imaging. In this case, a constant DC 
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bias is utilized to keep the volume coil on resonance for the 1H image, and thus no retuning 
procedure is needed to switch between two imaging nuclei. 
Finally, the limitations of coupled resonator paradigm for designing dual-frequency coils can 
be considered as follows.  For well separated frequencies, the frequency-dependant inductance of 
the sample coil will be significantly different at two working frequencies. However, it is difficult 
to implement a small copper loop inductor that has the same frequency-dependent inductance as 
the sample coil, and thus it will hinder the equivalence of sample coil and secondary resonator. 
The “in-phase” and “anti-phase” modes, as described previously, will not form as expected. 
Therefore, the strategy of using the coupled resonator model to fabricate a dual-frequency MRI 
coil is only suitable for close Larmor frequencies, e.g., 19F/1H and 13C/23Na.  
In conclusion, the present work describes a generalized strategy for designing 19F/1H dual-
frequency coils based on the coupled resonator approach. The tested birdcage and actively-
decoupled saddle coil at 4.7 T, as well as previously reported solenoid coil and open coil at 3 T 
(15,19),  demonstrated that this coil design can be readily adapted to diverse coil structures at 
different fields strengths.  A unique feature of this design is that it preserves the B1 field 
homogeneity of the RF coil at both resonant frequencies. By minimizing the susceptibility effect 
on image co-registration, this coil design enables direct co-registration of 19F and 1H images for 
localizing delivered 19F agent.  Because the size of the inductor in the secondary resonator is 
much smaller than the sample coil and it is positioned distal to the sample coil to minimize 
mutual uncontrolled inductive coupling between the two resonators, the secondary resonator 
inductor did not induce detectable perturbations of the magnetic field of the sample coil, nor loss 
of filling factor  (16). Finally, the nonlinear root-seeking procedure proposed in the current work 
can effectively calculate numerical solutions for the appropriate values of tunable capacitors. In 
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conclusion, in view of the anticipated utility of simultaneous 1H and 19F imaging and the 
potential availability of molecular imaging contrast agents with high 19F content this strategy 
may facilitate ultimate clinical adoption of such molecular imaging approaches given the 
availability of multispectral imaging systems (1). 
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3 NMR physics of PFC NP 
3.1 J-coupling of PFC NP 
3.1.1 Background 
In high resolution liquid NMR spectroscopy, there are two major mechanisms for spin-spin 
interaction. The strongest one is the direct dipole-dipole interaction between nuclear spins; and 
the other one is the indirect dipole-dipole interaction between nuclear spins mediated through 
electron spins. The first type of interaction (which will be discussed in greater detail in the next 
chapter) affects the NMR relaxation properties, (e.g., T1 and T2) of nuclear spins but does not 
lead to splitting of singlet resonant peaks into multiples because this effect is usually averaged 
out by fast molecular tumbling. The second type, however, generally results in peak splitting at 
the level of Hz for high resolution NMR. The indirect dipole-dipole interaction is also called J-
coupling, or scalar coupling, because the coupling terms in the Hamiltonian of nuclear spins can 
be described as scalars (1-2). 
In a weak coupling system, in which J-coupling constant is much smaller than the chemical 
shift difference among heterogeneous chemical groups, J-coupling is only related to the z 
component of the spins. In liquid NMR, the J-couplings in most PFC molecules (e.g., the 
coupling between CF3 and CF2, CF2Br and CF2 groups in perfluorooctylbromide (PFOB) 
molecule) are weak couplings. In most MRI scanners, because the imaging subjects are usually 
much larger than NMR tubes and hence pose more complicated geometry and chemical 
composition, B0 shimming over a larger spatial range is significantly coarser than that in NMR 
spectroscopy. For example, the typical full width at half maximal (FWHM) of a 1H (or 19F) 
spectrum for animal imaging at 4.7 T in vivo is ~100 Hz, which is an order of magnitude larger 
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than the J-coupling frequency. Hence instead inducing of peak splits, J-coupling in 19F MRI 
causes amplitude modulation of 19F resonant peaks, i.e., J-modulation (2-3).  
J-modulation originates from the phase difference among different peaks in a J-coupling 
induced multiplet. Because of J-modulation, the regular T2 decay of 19F nuclear spins becomes 
modulated into sinusoidal oscillations, the frequency of which is dependent on the J-coupling 
constant. Unlike field inhomogeneity, J-modulation is an intrinsic property associated with the 
molecular structure (independent of B0 field strength) and cannot be refocused by spin echoes. 
Such an oscillating behavior with regarding to the time of echo (TE) in spin echo imaging 
sequences dramatically shortens the apparent T2 value and reduces the detectable signal intensity 
in 19F imaging. On the other hand however, because the J-modulated spin echo signal is 
completely eliminated when TE=1/2J, this unique feature might also be employed as an imaging 
approach for selectively switching on/off certain PFC signals by adjusting the TE (4).  
In the present work, we aimed to study the relationship between RF bandwidth and J-
coupling modulation in 19F MRI of PFOB NP. The chemical structure and NMR spectrum of 
PFOB are shown in Figure 3.1. Because the CF3 group yields a 50% higher MR signal as 
compared to other CF2 groups, it is usually chosen as the central frequency for excitation and 
readout. The 19F nuclear spins in CF3 and the adjacent CF2 form a typical “A2B3” J-coupling 
system with a coupling constant of 12.3 Hz (4-6). In most practical imaging applications, J-
modulation of CF3 peak in spin echo imaging could be different from that in a simple 
spectroscopic experiment because imaging RF pulses (i.e., excitation (90±) and refocusing (180±) 
pulses) usually manifest relatively limited bandwidth so as to accommodate the slice selection 
imaging gradients. Therefore in order to achieve consistent quantitative 19F MRI of PFOB NP it 
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is important to understand the dependency of J-modulation of CF3 group in PFOB on the 
bandwidth of RF pulses (7).  
                            
Figure 3.1 Chemical structure and NMR spectrum of PFOB. (a) Chemical structure of PFOB 
molecule, the J-coupling constant between CF3 and the adjacent CF2 group is 12.3 Hz. (b) 
Representative MR spectrum of PFOB. 
3.1.2 Methods 
Theoretical calculation 
The Hamiltonian of the subsystem consisting of CF3 and CF2 groups in PFOB molecule can 
be written as  
 = 	
 + 	 + 	 + 	 + 	 + 2	
	 + 	
	 + 	
	 + 		 + 		 +
25,  [1] 
where 	’s are the z-component of the angular moment of 19F nuclear spins , ’s denote the 
chemical shift for each group, and   is the coupling constant between two groups which is 12.3 
Hz in PFOB. The initial state of this five spin sub-system, in the form of density matrix, before 
any RF pulses are played out is 
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 + 	 + 	 + 	 + 	.  [2] 
 For RF pulses with finite bandwidth and centered at CF3 frequency, the quantum operator 
format of a 90± pulse along x axis is 
  = 
 ! "#$ ⊗ 
 
! "#! ⊗ 
 
! "#& ⊗
 
! "#' ⊗ 
 
! "#( ,  [3] 
where  ’s are the x-component of angular moment of 19F nuclear spins, ⊗  denotes outer 
product, and ) = *+,2/*+,3) is the flip angle ratio between CF2 and CF3 group caused by 
the power drop down at CF2 peak from the central frequency due to the limited RF bandwidth. 
Similarly, the operator format of a 180± refocusing pulse along x axis is,  
 = "#$ ⊗ "#! ⊗ "#& ⊗ "#' ⊗ "#(,  [4] 
where ) factor is identical to that in 90± pulses, which is in agreement with the RF setting of our 
Varian small animal imaging system.  
Applying the Schrodinger equation, the operator describing the time evolution of a 
quantum state over time / can be written as  
0/ = 12,   [5] 
where  is the Hamiltonian of the system. Therefore, in a regular spin echo imaging sequence, 
the density matrix of the final state of the coupled CF3-CF2 subsystem can be calculated as  
 = [0 45  ∙  ⋅ 0 
45
  ⋅  

]
9 ⋅  ⋅ 0 45  ⋅  ⋅ 0 
45
  ⋅  

.       [6] 
Here we do not consider the regular T2 decay in the transverse plane. To account for T2 decay, 
we only need to multiply the final state function by a scalar 45/4.  
As the last step in the NMR/MRI experiment, when we measure magnetization in the 
transverse plane, the final signal intensity of CF3 in a spin echo sequence can be calculated by 
taking trace of the product of density matrix with the transverse angular momentum operator:  
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: = 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 +  + ].  [7] 
All calculations were performed analytically in a custom-designed program written in 
Mathematica (Wolfram, USA). 
Experimental investigation of J-modulation in 19F MRI 
High resolution NMR spectroscopy of PFOB NP was performed at a 7T Varian spectrometer. 
The sample was set spinning on an air cushion to improve B0 field homogeneity and a regular 
single pulse spectrum was acquired with TR = 10 s. To validate J-modulation, we performed spin 
echo spectroscopy of a 50 ml test tube containing 1% PFOB NP at Varian 4.7 T small animal 
scanner using a custom-built solenoid RF coil. In this experiment, TR=10 s, and TE was varied 
from 1 ms to 300 ms to capture the J-modulation profile of CF3 peak. MR spectroscopic 
quantification of PFOB content in the phantom was performed using an identical spin echo 
sequence with another sample of CE NP as an external reference. During the experiments, the 
bandwidths of both the 90± and 180± RF pulses were changed to examine the dependency of J-
modulation on RF bandwidth. 
Application of J-modulation on selective imaging 
We performed a phantom study to demonstrate the use of J-modulation for selective 19F MRI 
where PFOB was intentionally suppressed while a different type of PFC NP was selected for 
imaging. We filled an NMR tube with CE NP and inserted it into a larger glass bottle (1 cm in 
diameter). The empty space between two containers was filled with PFOB NP. Spin echo 
imaging in the transverse plane of the phantom was performed at 4.7 T with TR = 2 s, TE=10 
and 44 ms respectively, voxel size = 0.2 mm × 0.2 mm × 2 mm. The corresponding PFOB 
spectroscopy also was acquired using a spin echo spectroscopy sequence with the identical 
TR/TE values.  
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Figure 3.2 Theoretically calculated J-modulation profile of CF3 peak in PFOB molecule for 
different RF bandwidth. Narrow band excitation RF pulse reduces the effect of J-coupling 
according to theoretical calculation. 
3.1.3 Results 
Theoretical calculation of the J-modulation profile for different RF bandwidths () value) is 
presented in Figure 3.2. Three representative scenarios were considered. (1) Extremely narrow 
excitation/refocusing bandwidth: RF power was only transmitted to the CF3 group while CF2 
group was not affected, and PFOB did not exhibit any J-modulation induced amplitude 
oscillation in this case. (2) Extreme wide band excitation/refocusing: both the CF2 and CF3 
groups were fully excited and refocused. Maximal J-modulation was observed for the CF3 peak 
in this case. It is notable that at certain discrete points, when ;= = 2> + 1/2 (> > 0 is an 
integer), the signal intensity of the CF3 peak was completely suppressed by J-modulation. (3) 
With the use of a medium RF bandwidth for excitation/refocusing, both the oscillation amplitude 
and the frequency of J-modulation were decreased.  
Under conditions of high resolution MR spectroscopy (Figure 3.3a), we observed that J-
coupling caused splitting of the CF3 singlet into a triplet, as expected. The frequency difference 
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between two adjacent peaks in the triplet was  and the absolute intensity ratio among these 
peaks was approximately 1:2:1. By comparison, in low resolution spin echo spectroscopy, we 
observed that the intensity of the CF3 peak was highly modulated when we varied TE. However, 
if the RF bandwidth was narrowed, or if all of the RF pulses were highly selective, the CF3 peak 
did not exhibit any J-modulation effect (Figure 3.3b&c), which accorded with our theoretical 
calculation. The quantification of PFOB concentration with the use of a CE NP standard varied 
with both TE and RF pulse width (Figure 3.4). This result suggests that 19F spectroscopic 
quantification is highly dependent on the choice of TE and pulse width.  Therefore a shorter TE 
and a fixed choice of RF bandwidth should always be preferable in order to achieve consistent 
quantification.   
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Figure 3.3 NMR spectra of PFOB under different resolution and RF bandwidth. (a) High 
resolution NMR spectroscopy of the CF3 peak revealed peak split due to J-coupling. (b & c) J-
modulation under nonselective and selective RF pulses. 
To demonstrate the utility of  J-modulation to suppress background PFOB signal, from the 
PFOB spectroscopy, we suggest that a choice of TE = 44 ms might lead to a much lower CF3 
signal intensity as compared with other peaks, and a total elimination of PFOB background when 
imaging the other PFC component (which here is CE) selectively (Figure 3.5).  
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Figure 3.4 J-coupling effect on the acquired 19F MR signal from a PFOB phantom relative to that 
of a CE standard. The relative signal strength of PFOB, reflecting 19F MRI measured “quantity” 
of PFOB, varied at different excitation pulse width and TE, suggesting fixed pulse width (or 
bandwidth in the frequency domain) is required for quantitative PFOB MR spectroscopy.  
                                       
Figure 3.5 Images (and correpsonding spectra) of PFOB and CE with nonselective excitation. 
The center disk corresponds to CE while the outer circle rings correspond to the chemical shift of 
the CF3 peak from PFOB. 
3.1.4 Conclusion 
In this section, we have proposed a general theoretical framework for evaluating J-
modulation of PFOB in MR spectroscopy and imaging. We incorporated into our model the 
effect of finite RF bandwidth and theoretically proved that narrow band excitation/refocusing 
could reduce or even eliminate J-modulation effect in a spin echo sequence. High resolution and 
low resolution spectroscopy of PFOB NP confirmed the J-coupling induced peak spliting and J-
 50
 
modulation of the CF3 group. Furthermore, by carefully choosing the TE value in a spin echo 
imaging experiment, we could selectively switch on/off signal from the CF3 peak in PFOB. 
 
3.2 Oxygenation effect on the absolute quantification of 19F MRI 
3.2.1 Background 
The unique 19F MR signature of PFC NP has been exploited for conducting quantitative MRI 
because practically no background signal emanates from physiological tissue (8). However, the 
spin-lattice relaxation time (T1) of PFC emulsion is inversely correlated with oxygen 
concentration, which varies in different tissues (e.g., in tumor and artery). Therefore, it is 
necessary to choose in vivo acquisition parameters that minimize the oxygenation effect on 
quantitative 19F MRI-determined regional concentrations of PFC NP (9). Additionally, 
acquisition parameters should be optimized to maximize the SNR, which is a general concern for 
in vivo 19F MR applications. In this study, the effect of TR and TE on the accuracy of 
quantitative 19F MR were evaluated by mathematical simulation followed by in vivo validation.  
3.2.2 Methods 
Effect of oxygenation on 19F T1 
In vitro measurement of 19F R1 as a function of pO2 was acquired at selected O2 
concentrations (ranging from 0% to 100% O2 balanced with N2) by bubbling a gas mixture into a 
neat PFOB sample, a PFOB NP sample, a neat CE sample, and a CE NP sample for 30 minutes 
at room temperature. Experiments were performed on a 4.7 Varian small animal scanner, and 19F 
T1 measurements were made using inversion recovery spectroscopy with TR=10 s, and 10 
inversion delays (TI) ranging from 3 ms to 5 s. 
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Simulation 
Starting from the Bloch equations, simulations of spin echo spectroscopy sequences were 
preformed in Matlab (Mathworks, Inc.). First, the expected 19F signal intensity as a function of 
TR and TE was simulated to assess SNR. Subsequently, two simulations were conducted by 
setting the 19F T1 relaxation time of PFC NP to 0.9 s, thereby simulating normoxic conditions 
(21% [O2]), and 0.6 s, simulating hyperoxic conditions (100% [O2]) (10). The calculated 
oxygenation-induced quantification error was plotted as a function of TR and TE. The T2 for all 
simulations was set to be 0.3 s. The quantification fidelity was defined as Snormoxia/Shyperoxia, or the 
ratio of signal intensity between normoxia and hyperoxia.  
In vivo 19F MRI/S 
MR experiments were performed on an 11.7T Varian INOVA MR system. Three 
C57/BL6 mice under room air ventilation were intravenously injected with 20% v/v CE NP 
emulsion (4 mL/Kg) through the tail vein. At 3-hour post injection, mice were anesthetized with 
a standard dose of ketamine/xylazine. A solenoid 19F coil was placed on the right rear leg of the 
mice for in vivo imaging. A 1H scout image of the leg was first acquired to visualize the 
anatomy. Subsequently, a T1-weighted spin-echo 19F image (TR = 350 ms, TE = 16 ms) was 
acquired to visually examine the 19F signal intensity, followed by 19F T1 measurement using an 
inversion recovery spin-echo sequence (TR = 5 s, TI increases from 5 ms to 1.8 s with 0.2 s 
interval). Finally, quantification of regional PFC NP concentration was conducted with a 
previously reported 19F MR spin-echo spectroscopic method (TR = 0.3, 2.0, and 3.0 s) using 
trifluoroacetic acid (TFA) sealed in a pipette tip as a reference standard. Two sets of images were 
acquired for each mouse when breathing room air (normoxia condition) or 100% oxygen 
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(hyperoxia condition). Other parameters for 19F imaging were: RF excitation bandwidth, 350 Hz; 
number of average, 128; in plane resolution: 1mm µ 1mm; slice thickness: whole projection. 
3.2.3 Results 
               
Figure 3.6 Longitudinal relaxation rate of PFC NP and neat PFC liquid as a function of pO2 at 
4.7 T. 
R1 (longitudinal relaxation rate: 1/T1) of CE NP and different chemical groups in PFOB as a 
function of oxygen tension are summarized in (Figure 3.6). R1 of neat PFC and PFC NP were 
dependent on the oxygenation level, and the slope for the neat form was very close to that for the 
NP form of the same PFC component. Moreover, the CF3 and CF2Br group in PFOB also 
responded to oxygenation in a similar manner.  
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Figure 3.7 The relation between 19F quantification and TR/TE (simulation result). (a) 
Measurement fidelity (the ratio between 19F intensity under normoxia and hyperoxia) of the 
simulated 19F signal intensity for T1 = 0.9 s (normoxia) and 0.6 s (hyperoxia) at various TR. T2 
was set to be 0.3 s. (b) The normalized SNR of 19F MRI as a function of TR and TE within the 
same data acquisition time. T1 was set to be 0.9 s and T2 was set to be 0.3 s.   
                      
Figure 3.8 Dependence of 19F quantification on TR (in vivo result). (a) High resolution 1H image 
shows the position of the mouse leg and a TFA calibration standard (arrows). (b and c) T1 
weighted 19F image of mouse leg when the animal was under normoxia (b) or hyperoxia (c). (d) 
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Quantified 19F T1 of CE NP in mouse leg under normoxia and hyperoxia. (e) T1 and 
quantification difference (in percentage) of CE NP using different TR. 
Figure 3.7 shows the simulation result. The optimal parameter for achieving the highest SNR 
is TR≈1.5*T1. Additionally, the quantification difference between normoxia and hyperoxia 
conditions was less than 5% when TR ≥ 3 *T1. Figure 3.8 shows in vivo 19F MR result of mouse 
leg after PFC NP treatment. T1-weighted 19F signal in mouse leg under normoxia was apparently 
lower than that under hyperoxia. Correspondingly, a ~50% decrease of 19F T1 was observed 
from normoxia to hyperoxia conditions. Because of the oxygenation effect on 19F T1, a more 
than 100% quantification error of PFC NP concentration was observed when TR = 0.3 s. 
However, the quantification error was insignificant when TR = 3 s, i.e., ≥ 3*T1.  
3.2.4 Discussion 
We demonstrated that 19F MRI-determined PFC NP quantity was not sensitive to local 
oxygenation when TR> 3*T1. Results from mathematical simulations were in agreement with 
those determined from in vivo experiments. In clinical situations, tissue oxygenation is 
inhomogeneous in various organs such as tumors. Thus, a long TR (over 3 times T1) should be 
used for in vivo studies to guarantee that 19F MRI-determined PFC concentration accurately 
reflects the 19F spin-density.   
 
3.3  “Multi-chromatic” 19F MRI 
3.3.1 Background 
Conventional 1H MRI only affords a mono-chromatic readout of a single biomarker because 
water exhibits a single resonant frequency inside an external magnet. When the need for 
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simultaneous characterization of multiple biomarkers arises, alternative imaging approaches 
must be employed to generate multi-chromatic images to distinguish different types of 
biochemical targets. With unique 19F signals emanating from the core, PFC NPs enable a direct 
and quantitative readout of biomarkers with the use of 19F MRI. In contrast to organic molecules 
that are rich in proton atoms, PFCs exhibit a widely spread chemical shift (~100 ppm) (11). 
Recently, Sirinvias et al demonstrated the feasibility of manufacturing functional nanoparticles 
from five different PFC species (12). Because different PFC molecules manifest distinct 19F 
spectroscopic signatures, detection and identification of each PFC could be realized in one 
sample containing multiple PFCs. The feasibility of imaging two PFC components individually 
was first discussed by Mason et al, even though the PFC itself was not functionalized as a 
targeting contrast agent in their study (2). The first selective bi-chromatic imaging for two 
different PFCs as a molecular contrast agent was demonstrated ex vivo by Caruthers et al (13). 
However, the technical requirement for imaging multiple (>3) PFC species and the potential 
biomedical application of multi-chromatic 19F MRI with PFC NPs demands further experimental 
validation. 
3.3.2 Methods 
Multi-chromatic 19F MRI with extreme narrow RF bandwidth 
All NMR spectroscopy and MRI in this study were performed on an 11.7 T Varian 
scanner. For phantom imaging, five NMR tubes were filled with five previously studied neat 
PFC components, i.e., Perfluorooctyl-Bromide (C8F13Br, PFOB), Perfluorodecalin (C10F18, 
PFD), Perfluoro-12-Crown-4-Ether (C8F16O4, PF-12-CE), Perfluoro-15-Crown-5-Ether 
(C10F20O5, PF-15-CE or CE) and Perfluorooctane (C8F18, PFO), respectively. NMR spectra of 
each of these PFCs were acquired using a regular single pulse spectroscopy sequence with a 
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broad excitation and receiving bandwidth of 30 kHz and 40 kHz respectively. After acquiring the 
NMR spectra, one resonant peak of each PFC was chosen as the “signature frequency,” which 
could be selectively imaged for 19F multi-chromatic MRI. One chemical shift was selected as a 
signature frequency based on the following criteria: (1) the signature frequency of one PFC 
should not overlap with any resonant frequencies from any other PFCs; (2) the separation 
between any two selected signature frequencies should be as wide as possible; (3) if multiple 
peaks exist and meet criteria (1) and (2), the one that exhibits the strongest NMR signal should 
be chosen. Finally, the signature frequency of each of PFC was determined to be: 26.8 ppm for 
PFOB, -23.9 ppm for PFD, 1.7 ppm for PF-12-CE, 0 ppm for PF-15-CE, and 17.5 ppm for PFO, 
respectively. 
For multi-chromatic imaging, all five NMR tubes containing the aforementioned PFC 
species were placed inside a 50 ml tube filled with DI water. A fast spin echo sequence (FSE) 
was employed to identify each PFC separately by selectively exciting and refocusing at the 
signature frequencies. In order to realize complete separation and avoid potential cross talk 
among different PFCs, we employed a sinc shape pulse with 8 ms duration for both 90± and 180± 
pulses in the FSE sequence. The frequency bandwidth of such a long pulse was as narrow as 700 
Hz, which is sufficient to distinguish between the closest spaced signature frequencies of all five 
PFCs. Other imaging parameters were: echo train length = 8, TR = 2 s, TE = 20 ms, in plane 
resolution = 0.25 × 0.25 mm, slice thickness = 1 cm. After 19F MRI, transmit and receive offset 
was switched to 1H frequency and a regular gradient echo sequence was employed to acquire a 
1H image to visualize the structure of the phantom. The parameters for 1H MRI were TR = 100 
ms, TE = 5 ms, in plane resolution = 0.25 × 0.25 mm, slice thickness = 1 cm, flip angle = 30±.  
Multi-chromatic MRI in macrophage cellular imaging 
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RAW 267.3 macrophage cells (n=3 for each group) were cultured in gelatin coated T75 
flask to reach around 80% confluence, and a mixture of CE NP and PFOB NP was added to the 
culture media at concentrations of 2, 5, 10 and 20 µl/ml. The mixed PFC NP contained 75% 
volume fraction of plain PFOB NP and 25% of plain CE NP. After 2-hour incubation, flasks 
were washed with PBS for 3 times and then cells were counted, harvested and spun down to 
form loose pellets. 19F spectroscopic quantification was performed for all cell samples with 10 µl 
trifluoroacetic acid (TFA, 1% volume concentration) sealed in a pipette tip as an external 
standard. Multi-chromatic imaging of CE NP, PFOB NP and TFA standard was performed using 
the protocol described previously. 
In vivo demonstration of multi-chromatic MRI 
A Swiss Webster mouse was anesthetized with ketamine/xylazine. The left leg of the 
mouse was secured to the inner surface of a custom-built 19F/1H dual frequency solenoid coil. 10 
µl of CE NP were injected into the foot pad of the left leg while 50 µl of PFOB NP was injected 
intramuscularly into the calf. A 1H gradient echo image was firstly acquired to visualize the 
anatomy of the leg, with TR = 100 ms, TE = 5 ms, thickness = 1 mm, resolution = 0.5 mm× 0.5 
mm. Without retuning the dual-frequency probe, 19F spectroscopy was acquired at the exact 
same position over the whole leg. A receiving bandwidth of 40 KHz was used to cover the 
widely spread chemical shifts of PFOB. By selectively exciting and receiving at the signature 
frequency of CE and PFOB as described in previous sections, multi-chromatic 19F MRI was 
performed to map the distribution of both PFC NPs. The detailed imaging parameters were as 
follows: echo train length = 8, TR= 2 s, TE = 20 ms, in plane resolution = 1 mm µ 1 mm, slice 
thickness = 2 mm. 
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3.3.3 Results 
NMR spectra of PFOB, PFD, PF-12-CE, PF-15-CE and PFO are shown in Figure 3.9. 
Signature frequencies selected for 19F MRI were marked and color coded to represent the 
different PFCs. The closest signature frequencies between two PFCs were from PF-15-CE and 
PF-12-CE, which were only 800 Hz apart. Because of the extremely narrow excitation 
bandwidth (700 Hz) used in this study, we were able to identify and image each of the PFC 
species individually. MRI images of all PFC components (Figure 3.10), normalized to the 
maximal intensity within the region of interest (ROI), were color coded with the same color as 
marked in the corresponding spectra. Because we always placed the excitation and readout 
central frequency at the signature frequency of the PFC that we aimed to image, chemical shift 
artifact was not present in the 19F images and all 19F images automatically co-registered well 
with the 1H background image. Moreover, the J-coupling effect was not present in these images 
because both the multi-echo MRI paradigms and the selective excitation suppress the indirect 
coupling between multiple chemical groups within a PFC molecule.  
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Figure 3.9 MR spectra of five PFC components. One signature frequency (color coded) of each 
PFC component was selected for multi-chromatic 19F MRI 
             
Figure 3.10 Multi-chromatic 19F MRI of a phantom containing five PFC components. 
In vivo result 
Two imaging slices from the mouse leg (Figure 3.11) revealed distinct localizations of 
CE NP and PFOB NP representing different injection schemes. Good separation between two 
 60
 
PFC NPs was achieved in the 19F image, as a demonstration of the feasibility for multi-chromatic 
19F in vivo. 
                  
Figure 3.11 In vivo multi-chromatic 19F MRI of mouse leg. (Blue: CE, Yellow: PFOB) 
                 
Figure 3.12 Multi-chromatic 19F MRI for macrophage cellular imaging. (a) Multi-chromatic 19F 
of macrophage pellet. (b) Quantification of both PFOB and CE NP at different incubation dose. 
(c) Internalized concentration of PFOB and CE NP are linearly correlated. 
Cellular imaging result 
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Representative multi-chromatic images and spectroscopic quantification are shown in 
Figure 3.12a&b. The TFA standard and internalized CE and PFOB NP in cell pellet are 
visualized individually in 19F MRI. The 19F quantification revealed an increase of retained NP 
concentration in cells as the incubation concentration increased. However, there was no 
significant difference between the 10 µl/ml and 20µl/ml groups suggesting that macrophages 
were saturated at the high dose of PFC NP. As shown in Figure 3.12c, the retained concentration 
of CE NP was linearly correlated with PFOB NP and the ratio between them was identical to that 
in the NP mixture used for incubation (1:3). These results confirmed that macrophage cells 
endocytosed both NPs in the same manner if they possessed identical size and surface charge. 
The specific chemical contents inside PFC NP did not seem to affect the cellular update in 
macrophages. 
3.3.4  Discussion 
In this work, we have proposed and verified a paradigm for multi-chromatic 19F MRI 
imaging. We validated this technique in a phantom containing five different PFC components, 
each one of which could be imaged via MRI individually. Using multi-chromatic 19F MRI as a 
tool, we investigated the cellular update of two different PFC NPs in macrophages. We 
quantitatively defined the saturation level of macrophage endocytosis for PFC NP and confirmed 
that PFC component did not affect the internalization of these particles into cells. We also 
demonstrated our multi-chromatic 19F MRI technique in vivo for visualizing two different 
intramuscularly injected PFC NPs.  
Currently, multiple clinical and preclinical targeting mechanisms have been proved to be 
effective in vivo using functionalized PFC NP and associated imaging techniques. These PFC 
NPs with targeting ligands actively bind to various biomarkers in cancer and cardiovascular 
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disease, such as αvβ3 (14) and αvβ5 (15) in rabbit tumor and atherosclerotic angiogenesis (16), 
fibrin (17) and thrombin during acute coagulation (18), and VCAM during microvascular 
inflammation of chronic renal disease (8). Multi-chromatic 19F MRI could provide a promising 
imaging approach for registering multiple disease biomarkers simultaneously and investigating 
the pathophysiological interaction between different disease epitopes.  
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4 Paramagnetic relaxation enhancement of PFC NP 
4.1 Introduction 
Molecular imaging with ligand-targeted 19F nanoparticles (NP) is an emerging diagnostic 
approach for magnetic resonance imaging (MRI) and spectroscopic detection and classification 
of various diseases (1). When combined with conventional 1H MRI, 19F MRI yields high 
resolution anatomic information and enables spectroscopic quantification of disease biomarkers 
(2-4). Among the available 19F MR contrast agents, perfluorocarbon (PFC) NPs have shown 
potential for imaging of cancer and atherosclerosis both as vehicles of paramagnetic agents (5-7) 
and as intrinsic fluorine signaling entities (8-11). The high concentration of 19F in PFC NP, the 
lack of innate background 19F signal in tissues, and the demonstrated safety of the basic agent 
(12), position targeted PFC NP as a promising contrast agent for molecular MRI with significant 
translational potential (4).  
However, the 19F MR signal intensity of PFC NP is limited by two factors that impose 
hurdles for clinical utilization. First, despite its high signal nucleus, the total amount of 19F that 
can be injected still is much less than the natural abundance of 1H in tissues (13), which 
challenges signal-to-noise requirements in clinical imaging scenarios. Second, the long 19F T1 for 
PFC NP, which is roughly equivalent to that of neat PFC liquid, challenges efficient data 
acquisition (14). Lee et al originally reported that Gd can function as a relaxation agent for 
fluorine under certain circumstances (15).  Recently, Neubauer et al showed that coating PFC NP 
with paramagnetic Gd chelates markedly accelerates relaxation of PFC molecules and thus is 
indeed useful for enhancing the 19F signal within the limited timeframe typically available for in 
vivo imaging (16). Nevertheless, in order to better facilitate its further application in vivo and 
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provide guidance for the chemical synthesis of this type of paramagnetic NP, a first-principle 
analysis of the special relaxation properties of 19F spins in paramagnetic PFC NP is of great 
importance.  
Previous investigations of water translational motion used models of pure outer-sphere 
relaxation to study spin dynamics of 1H that are separated from free radicals by lipid bilayer 
membranes, silicon surfaces, or protein surfaces (17-19). In this report, we suggest similar 
applications to the specific case of assessing the paramagnetic relaxation enhancement of 19F 
nuclei in the core of PFC NP. To do so, the Solomon, Bloembergen and Morgan theory (SBM 
theory) (20-22) was applied to the outer-sphere interaction between 19F spins and Gd ions that 
are separated by lipid monolayer. The modeling framework for the paramagnetic relaxation 
enhancement recognizes that at clinical field strengths the zero field split effect can be neglected 
(23).  
For aqueous solutions, the total paramagnetic relaxation enhancement is contributed by two 
compartments: inner-sphere and outer-sphere relaxation (24). The inner-sphere relaxation 
requires a direct coupling interaction between the imaging/signaling molecule (e.g., water for 1H 
MRI, or PFC for 19F MRI) and a paramagnetic ion (e.g., Gd3+) over a short time interval to 
facilitate energy transfer. In contrast, outer-sphere relaxation is caused by the translational 
diffusion of the imaging molecule around the paramagnetic center without the need of direct 
binding (25-27).  For most paramagnetic contrast agents, the inner-sphere relaxation (i.e., the 
direct binding effect) is the dominant mechanism for relaxation enhancement. However, inner-
sphere relaxation does not exist in PFC NP because the PFC core is well separated from surface 
Gd ions by a lipid/surfactant monolayer (Fig. 4.1a). The relaxation enhancement in this case is 
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caused solely by the diffusion of encapsulated PFC molecules to the proximity of Gd on the 
outer lipid monolayer surface through an outer-sphere relaxation mechanism.    
Based on this physical model, we sought to apply these observations to elucidate the 
interaction of a living cell with such a NP system after internalization into endosomal 
compartments, and to detect the actual break down of the particle into its component parts (28). 
We show that endocytosis results in an alteration in 19F relaxation as Gd chelates are stripped 
from the NP surface, thus returning the 19F T1 to its native relaxation state without paramagnetic 
relaxation enhancement. These interactions reveal a “19F relaxation switch” phenomenon that can 
track the activity of the endosome as it degrades the ingested material, which might be of use 
experimentally for dynamic monitoring of the function of such intracellular organelles. 
 
4.2 Theory 
4.2.1 Boundary conditions and physical parameters of PFC NP with Gd coating 
The structure of paramagnetic PFC NP is illustrated in Figure. 4.1a. The NPs are the PFC 
droplets in a PFC-water emulsion system and exhibit diameters ranging 100-300 nm. Because 
the hydrophilic head groups of the lipid monolayer establish an ultimate boundary against the 
translational diffusion of PFC molecules toward the Gd on the outer surface, we follow the 
treatment in (29) to introduce the concept “distance d of closest approach”, where d is defined as 
the smallest distance between a PFC molecule in the core of the NP and the Gd ion layer on the 
surface of NP. Practically, d is a parameter determined by the length of the linker attaching the 
Gd chelate to the hydrophilic surface of the lipid layer, as well as by the maximal penetration 
depth of PFC molecule into the hydrophobic tails of the lipid layer (5, 19). To simplify the 
modeling, the diffusion of the PFC molecule is assumed to be unrestricted with a diffusion 
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coefficient D as long as its distance to the Gd layer is greater than d. Finally, the Gd chelates on 
the lipid layer are assumed to be randomly distributed and the Gd concentration is described by a 
Gd/lipid molar ratio [Gd]. These physical properties of NP influence the enhancement of 
longitudinal relaxation rate ∆R1 of  PFC NP (30), which is defined as the difference between R1 
(R1=1/T1) of Gd-coated NP and non-Gd-coated NP,  
1 1 1( ) ( ).R R NP withGd R NP without Gd∆ = −   [1]                                                                
                
Figure 4.1 Chemical structure of paramagnetic PFC NP. (a) Illustration of configuration of 
paramagnetic PFC NP. Direct contact between Gd ions and PFC molecules is prevented by the 
lipid monolayer. (b) and (c), Chemical structure and NMR spectra of CE and PFOB. (d) and (e), 
Chemical structure of DTPA-BOA-Gd and DOTA-PE-Gd shows the longer linker chain of 
DOTA-PE-Gd as compared with DTPA-BOA-Gd.  
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4.2.2 Theoretical calculation of paramagnetic relaxation enhancement in PFC NP 
Paramagnetic relaxation enhancement of PFC NP is caused by the fluctuation of dipolar 
energy between the electron spin S
r
 from the Gd ion and the nuclear spin I
r
 from the PFC 
molecule (21). Specifically, this dipolar interaction Hamiltonian takes the following form 
2
0 0 1 13
* *
1 1 2 2 2 2
1[3( )( ) ] [ ( )] ( )
4
( ) ]
I S
IS Z Z Z Z
IS
Z Z
H I r S r I S F A I S I S I S F A I S I S
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F A I S I S F A I S F A I S
γ γ
+ − − + + +
− − + + − −
= • • − • = − + + + +
+ + +
r rr rh r r
,     [2] 
in which 2 30 (1 3cos ) / ISF rθ= − , 31 sin cos /i ISF e rϕθ θ=  , and 2 2 32 sin /i ISF e rϕθ=  represent three 
components of the dipolar interaction that are proportional to the second rank spherical 
harmonics; Iγ  and Sγ  are the gyromagnetic ratios for relevant nuclear and electron spin; and 
2
0 I SA γ γ= h ,  21 3 / 2 I SA γ γ= − h  and 22 3 / 4 I SA γ γ= − h  are three real constants. Based on the 
theoretical treatment proposed by Solomon (21), the relaxation enhancement of I
r
 contributed by 
a single nuclear-electron spin pair can be written as  
2 2 2
1 0, 1, 2,
1 3 3( 1)[ ( ) ( ) ( )]
12 2 4I S pair I S pair I pair I S
r S S J J Jγ γ ω ω ω ω ω∆ = + − + + +h , [3]                   
in which 
,
( 0,1, 2)q pairJ q =  is the spectral density of the correlation function for the qth 
component of dipolar interaction qF ; S  is the quantum number for the total electron spin; Iω  
and Sω  are the Larmor precession angular frequencies for nuclear and electron spin, 
respectively.  Specifically, the spectral density for correlation function of the qth component of 
the dipolar interaction is defined as (29) 
* *
,
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∞
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−∞
= + = +∫ F ,    [4]        
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in which F  represents Fourier transform, and the average is taken over t  with theτ  and ω  
forming a Fourier transform pair.  
The magnitude of a specific component of dipolar interaction qF  is modulated by two 
factors:  1) for a PFC molecule, the diffusion-induced change of the relative distance and angle 
θ , ϕ  between a nuclear-electron spin pair (31); and 2) the propensity of the anchored Gd chelate 
on the lipid surface to undergo vibration, reorientation of the linker chain, and lateral diffusion 
across the membrane that might modulate nuclear-electron interactions (32). In the present study, 
the second mechanism is negligible because the lateral diffusion of Gd chelate on the lipid 
surface is restricted and much slower than is the Brownian diffusion of PFC inside the NP (32). 
Thus, we assume that the diffusion of PFC molecules represents the major source for the 
fluctuation of dipolar interactions. The probability for a single PFC molecule to move from 
position 0R
uur
 to R
ur
 after time τ  was modeled as a Gaussian function (33) 
2
0( )
3/2 4
0( , ; ) (4 )
R R
DP R R D e ττ pi τ
−
−
−
=
ur uur
ur uur
,    [5]                                                                                        
where D is the diffusion coefficient of PFC molecule.  
 The coordinate system used in Eq. 2 to define qF  is centered at the electron spin. The z-
axis is along the direction of the external magnetic field. To facilitate modeling in a symmetric 
way, an alternative coordinate system, the “NP reference frame”, was defined with the origin 
positioned at the center of the NP and the z-axis aligned in the direction of external field. The 
expression of qF  in the NP reference frame then depends on the position of the electron spin. 
Taking into account all possible positions of a nuclear spin interacting with a single electron spin 
at position ( , )Gd Gdθ ϕ  on the surface of NP, the spectral density can be rewritten in the following 
form 
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where the integral is taken over the space inside the NP. Considering the spherical symmetry of 
the NP and summing up the contribution from all the Gd ions and following the calculation 
proposed by Abragam (29), the spectral densities including all the electron spins are in the form 
of  
3
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in which 5/2( )J kx  is the Bessel function and qC ’s are real constants with the relationship 
0 1 2: : 6 :1: 4C C C =  due to normalization factors for qF ’s (21). The absolute value of qC ’s is 
determined by the separation of surface Gd ions (16). Because the gyromagnetic ratio of the 
electron spin is more than 1000x greater than that of the nuclear spin, both I Sω ω−  and I Sω ω+  
would be much greater than Iω . Careful examination reveals that  0, ( )total I SJ ω ω−  and 
2, ( )total I SJ ω ω+   are negligible compared to 1, ( )total IJ ω , so that the final form for the relaxation 
enhancement for the NP is: 
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h .                 [8] 
Thus, enhanced relaxation is due primarily to the dipolar interaction terms ZI S+  and ZI S+  
corresponding to 1q =  in Eq. 2. 
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4.3 Material and Methods 
4.3.1 NP formulation and characterization 
 The actual PFC NP emulsion is composed of 20% (v/v) of perfluoro-15-crown-5 ether 
(CE; Exfluor Research Corp., USA) or perfluorooctylbromide (PFOB; Minnesota Manufacturing 
and Mining, USA), a 2.0% (w/v) surfactant commixture, and 1.7% (w/v) glycerin, with water 
comprising the balance. CE has twenty chemically equivalent fluorine atoms and produces a 
single 19F NMR peak (Figure 4.1b); PFOB exhibits seven different chemical shifts and J-
coupling splitting (Figure 4.1c). For incorporating the paramagnetic ions, the surfactant 
commixture is comprised of lecithin (Avanti Polar Lipids Inc, USA), dipalmitoyl-
phosphatidylethanolamine (Avanti Polar Lipids Inc., USA) and two possible lipophilic 
gadolinium chelates, namely Gd-DTPA-BOA (Gateway Chemical Technologies, USA) and Gd-
DOTA-PE (Dow Chemical Co., USA) with the concentration of 30 mol% Gd. The relevant 
difference between the two Gd chelates is that Gd-DTPA-BOA has shorter linker arm length 
than does Gd-DOTA-PE, which causes the DTPA-BOA linked Gd to abut the surface of the NP 
(34) (Figure 4.1d and e), whereas the DOTA-PE linked Gd is more remote. The particle sizes 
were determined at room temperature with a dynamic light scattering particle sizer (Brookhaven 
Instruments Corp., USA).  Diffusion coefficients of the neat liquid CE and PFOB were measured 
at room temperature with a pulsed gradient spin echo sequence on a 4.7 T Varian INOVA small-
bore imaging system (35). 
4.3.2 Monte-Carlo simulation 
 To confirm the non-uniform field distribution in the PFC core, a Monte-Carlo simulation 
of the Gd-induced magnetic field inside the PFC NP was performed. We chose 1,800 randomly 
sampled points on the surface of NP (diameter, 200 nm) as the locations for Gd ions, and set the 
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distance between Gd to the surface of NP at 2 nm. For each point inside the NP, the contributions 
from all dipolar magnetic fields produced by Gd ions were summed. In the simulation, the 
magnitude of magnetizations of Gd ions was set to be constant and their directions set along the 
external magnetic field, i.e., the z-direction (because of the short relaxation of electron spin, the 
magnetic moment of a single spin was treated as in a thermal equilibrium state). 
4.3.3 T1 measurement and experimental data fitting 
 T1 of NP samples was measured with an inversion recovery sequence on a 3 T Philips 
imaging system, a 4.7 T Varian imaging system, a 7 T Varian NMR spectrometer, and an 11.7 T 
Varian imaging system. For PFOB, the T1 was measured on the CF3 peak in its NMR spectrum 
(36-38). According to Eq. 8, the undetermined constant 1C  notwithstanding, four definite 
parameters contribute to the relaxation enhancement 1R∆ : 1) diffusion coefficient D , 2) Larmor 
frequency Iω , 3) particle size r , and 4) distance of closest approach d . The only parameter that 
cannot be measured directly is the distance of closest approach d . Therefore, based on the NP 
structural parameters and the measured relaxation enhancement, we opted to fit the experimental 
data to Eq. 8 and test if it gave a reasonable estimate for d . The nonlinear fitting of the 
experimental data to the theoretical prediction was executed in Mathematica (Wolfram Inc, 
USA) based on the least squares principle. 
4.3.4 In vitro demonstration of “19F relaxation switch” after cell internalization 
 αvβ3-integrin expressing RAW 267.7 murine macrophages (passage 4 or 5) were used for 
all experiments to elicit active endocytosis of PFC NP. Incubations were carried out in gelatin-
coated T75 cell culture flasks with αvβ3-integrin targeted CE NP anchored with Gd-DTPA-BOA 
(2 µl/ml). After being incubated for 2, 24 or 48 hour, cells were washed with PBS three times 
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and then centrifuged to obtain pellets. 19F spectroscopic quantification was performed at an 11.7 
T Varian small animal imaging scanner using previously reported methods (39). The 1H and 19F 
longitudinal relaxation properties of the cells were measured on a 4.7 T Varian small animal 
imaging scanner with an inversion recovery sequence. To confirm that other factors (e.g. 
intracellular oxygen gradient) did not contribute to the change of 19F T1 after internalization, the 
19F T1 of internalized plain CE NP , i.e., without Gd chelates, was also measured. 
 For fluorescent microscopy of internalized PFC NP, another group of cells were 
incubated with αvβ3-integrin targeted PFC NP colabeled with Alexa Fluor 594.  Subsequently, 
cells were fixed with 4% paraformaldehyde for 30 mins, mounted with DAPI media 
[VECTASHIELD Inc., USA], and imaged with Olympus BX61 fluorescent microscope.   
 
4.4 Results 
4.4.1 Inhomogeneous magnetic field in NP  
 As shown in Figure 4.2, the magnetic field fluctuates considerably near the surface of NP 
but is relatively homogeneous in the central part of NP. In addition, since the direction of 
external field is the z-direction, the Gd-induced magnetic field is not isotropic and exhibits 
slightly different distributions on the xy and xz-plane. 
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Figure 4.2 Monte-Carlo simulation of Gd-induced magnetic field inside NP. X-component of the 
field strength on the xy-plane and xz-plane of the NP are depicted in (a) and (b), respectively. 
Inhomogeneous field distribution is visually appreciable close to the surface of the PFC NP.  
4.4.2 Effect of the structural parameters on 19F 1R∆  
 Figure 4.3a illustrates the dependence of 19F 1R∆  on the radius of the NP according to Eq. 
8. Because the paramagnetic ions are located only on the surface of the PFC NP instead of 
mixing in the PFC core, the surface to volume ratio of the PFC NP results in the 1/ r  
dependence of 1R∆ . This result agrees with the classical paramagnetic relaxation enhancement  
phenomenon for an aqueous solution, in which 1R∆  is proportional to the volume concentration 
of paramagnetic ions (14). Figure 4.3b plots 1R∆  as a function of the distance of closest approach 
d . Selected combinations of diffusion coefficient D  and external magnetic field B  were 
examined. In comparison to the 61/ d  dependence for pure inner-sphere relaxation scenarios, e. 
g. immersion depth measurements (40) and protein structure determinations (41), it is evident in 
Figure 4.3b that the decay of 1R∆  for paramagnetic NP relative to d  is slower, in agreement with 
previous results found by Polnaszek et al (18). Figure 4.3c depicts the relation between 19F 1R∆  
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and the external field strength 0B . Selected combinations of distance of closest approach d  and 
diffusion coefficient D  are shown in different line styles. The longitudinal relaxation 
enhancement of NP decreases monotonically when the external magnetic field increases over the 
range of the field strengths plotted. Figure 4.3d illustrates the dependence of 1R∆  on the diffusion 
coefficient D  of the PFC molecule. The effect of D  is complex and non-monotonic: the 
maximal relaxation enhancement occurs for certain optimal combinations of d , D  and Larmor 
frequency Iω . The potential underlying mechanism for this non-monotonic behavior is 
considered in detail in the Discussion.  
          
Figure 4.3 Theoretical predication of relaxation enhancement as a function of particle 
configuration. (a) Normalized relaxation enhancement 1R∆  as a function of particle radius. The 
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value of 1R∆  is normalized to that when r =25 nm. 1R∆  is inversely proportional to the radius of 
NP. (b)
 
1R∆  as a function of closest distant of approach. The radius of NP r  is fixed to be 100 
nm. The value of 1R∆  when D =50 µm2/s, d =0.5 nm and B =1.5 T is normalized to one. The 
curve 61/ d  was plotted as the reference. (c) 1R∆  as a function of external magnetic field. r  was 
set to be 100 nm. The value of 1R∆
 
when D =50 µm2/s , d =0.5 nm and B =1.5 T is normalized 
to one. (d) 1R∆  as a function of diffusion coefficient of PFC. The radius of NP r  is fixed to be 
100 nm. The value of 1R∆  is normalized to the maximum value in the graph.  
 
4.4.3 Experimental validation 
 Diffusion coefficients of neat CE and PFOB measured at room temperature were 210 
µm2/s and 200 µm2/s, respectively. The mean diameters of three types of paramagnetic NP were: 
382 nm (polydispersity, 0.177) for PFOB NP with Gd-DOTA-PE, 270 nm (polydispersity, 
0.082) for PFOB NP with Gd-DTPA-BOA, and 150 nm (polydispersity, 0.081) for CE NP with 
Gd-DTPA-BOA.  Figure 4.4a illustrates the longitudinal relaxation rates of CE NP, CE NP with 
Gd-DTPA-BOA, PFOB NP, PFOB NP with Gd-DTPA-BOA, and PFOB NP with Gd-DOTA-PE 
at different magnetic fields. For comparison with the theoretical prediction (see Figure 4.4b), we 
used the relaxation enhancement of CE NP loaded with Gd-DTPA-BOA at 3 T as the reference 
to eliminate the effect of the constant 1C . The ratio between 1R∆  of CE NP with DTPA-BOA-Gd 
and that of all NP at various fields were fitted to Eq. 8. The fitting variable, the distance of 
closest approach d, was the only parameter that varied among NPs due to the different chelate 
linker lengths and penetration depths. The fitting results for the distances of closest approach are: 
CE NP with Gd-DTPA-BOA, d = 0.9 nm; PFOB NP with Gd-DTPA-BOA, d =1.0 nm; and 
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PFOB NP with Gd-DOTA-PE, d = 1.4 nm. Note that according to the chemical structure, the 
length of all these linker chain is on the order of 1 nm, and that the Gd-DTPA-BOA has a shorter 
linker than does Gd-DOTA-PE (34). Therefore, the experiment illustrates that the theoretic 
prediction is qualitatively accurate. Additionally, the fitting result for d  also provides a realistic 
experimentally measured range for the distance between the diffusing 19F spins and the anchored 
Gd ions. 
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Figure 4.4 Theoretically predicted and experimentally measured relaxation of paramagnetic PFC 
NP. (a) Experimentally measured 1R  at various magnetic field strengths. (b) Relaxation 
enhancement 1R∆  was extracted from the experimental data and compared with the theoretical 
fitting. Fitting result gives reasonable estimate of closest distant of approach
 
d
 for PFC NP with 
DTPA-BOA-Gd and DOTA-PE-Gd. 
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4.4.4 Biological application for tracking endosome function 
 Fluorescent microscopy confirmed the intracellular localization of Alexa Fluor 594 in 
treated macrophages, suggesting internalization of PFC NP (Figure 4.5). Quantitative 19F MR 
spectroscopy (Figure 4.6a) showed that the number of PFC NP per macrophage increased 
progressively within the first 48 hours following treatment with Gd-DTPA-BOA coated PFC NP. 
The delivery of Gd chelates on PFC NP to macrophage cells was confirmed by the progressively 
decreasing 1H T1 (or alternatively, increasing relaxation rate, 1/T1) (Figure 4.6b), reflecting the 
local paramagnetic effect of Gd. However, after endocytosis, the 19F T1 of PFC NP rapidly 
recovered to the baseline value of plain PFC NP (i.e., without Gd coating) within 2 hours (Figure 
4.6c). The 19F T1 of internalized PFC NP remained at that level despite the continuous cellular 
uptake of PFC NP. Based on the theoretical prediction of Eq. 8, the shortened 1H T1 but fully 
recovered 19F T1 suggested that Gd chelates were rapidly separated from PFC NP upon endocytic 
ingestion. 
 
Figure 4.5 Fluorescent microscopy of PFC-NP treated macrophages with incubation time (a) 2 
hours, (b) 24 hours, and (c) 48 hours. Blue=DAPI, red= Alexa Fluor 594, red scale bar = 10 µm. 
 81
 
4.5 Discussion 
 Targeted paramagnetic PFC NPs represent a promising construct for quantitative 
molecular imaging with magnetic resonance methods (4). In order to optimize such contrast 
agents for use in biological environments that can present multiple variables that might influence 
19F relaxivity such as oxygen tension, pH, temperature, blood flow, and imaging field strength, it 
is critical to understand 19F relaxation phenomena from first principles. This requirement is also 
applicable to the relationship between relaxation properties and the physical composition of the 
NP itself which can vary in size, shape, and lipid and PFC composition.  
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Figure 4.6 Quantitative 19F spectroscopy of internalized paramagnetic PFC NP. Number of 
paramagnetic PFC NP per cells (a), proton longitudinal relaxation time (b), and fluorine 
longitudinal relaxation time (c) after 2, 24, 48 hour incubation. Data represent mean ≤ SD (n=4). 
 In this work, we have developed a theoretical framework for understanding these 
interactions and demonstrated the first order concordance between theory and measurement.  
Several novel conclusions can be stated.  Firstly, paramagnetic relaxation enhancement of 19F 
nuclei is observed in PFC NP because of the discrete distribution of Gd ions on the microscopic 
scale that gives rise to an inhomogeneous magnetic field when closely opposed to the particle 
surface.  Secondly, the existence of a lipid monolayer barrier prevents the direct binding between 
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Gd ions and PFC molecules resulting in a pure outer-sphere relaxation mechanism that is the 
basis for the concordant predicted and observed relaxation behavior. Lastly, when Gd chelates 
are stripped from the nanoparticle surface after cell internalization, a “19F relaxation switch” 
occurs, revealing the transition from intact bound particle to processed constituents, which is 
indicative of the intracellular endosomal material processing function. 
 According to SBM theory (29), paramagnetic relaxation enhancement  of a PFC molecule 
with nuclear spin I
r
 inside the NP is attributed to the time-dependent dipolar interactions 
between the 19F nuclear spin and the superposition of the magnetic fields produced by all 
electron spins S
r
 from the Gd ions (21). Interestingly, considering classical electromagnetism, a 
sphere with an ideally polarized magnetic shield should manifest a homogeneous internal 
magnetic field distribution (42) wherein the dipolar interactions remains constant as PFC 
molecules diffuse. However, because of the limited thickness of the lipid monolayer (around 1.5 
nm), the distribution of Gd ions on the surface of PFC NP should be treated as discrete once the 
point of interest is close enough to the surface (i.e., on the same order of the distance between 
two neighboring Gd ions on the NP surface, which is around 1.4 nm for a NP with a diameter of 
170 nm (16)). 
 It is notable that the distance of closest approach fitted from the experimental data is 
smaller than 1.5 nm, which approximates the length of the hydrophobic tail of the lipid molecule 
(16). The PFC molecules are known to penetrate the membrane lipid layer through diffusion and 
act to reduce membrane tension, which explains their ability to come into sufficiently close 
proximity to the Gd atoms on the NP surface to experience relaxation enhancement (37-38,43). 
Despite departing from the traditional 61/ d  dependence (Figure 4.3b) for outer sphere 
interactions, the paramagnetic relaxation enhancement effect still decreases dramatically with 
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increasing d , demonstrating that a Gd coating situated close to the surface of the PFC NP 
favorably enhances the relaxation of NP. These data are consistent with previous works from our 
group that have shown that when a relatively larger d  has been achieved by simply mixing of 
the PFC NP emulsion and standard soluble Gd chelates that are not bound to the NP, the freely 
diffusible Gd ions around the NP exert no effect on the relaxation property of PFC NP (16). 
These results suggest that chelates with short linker chains would be preferred to form the 
paramagnetic coating.  
 With respect to the outer-sphere relaxation mechanism, two time scales are involved in 
the relaxation process for PFC nuclear spins: the time scale of diffusive motion 2 /d D , and the 
period of the Larmor precession 1/ Iω  (44). From the expression of 1R∆  (Eq. 8), a close match 
between these two time scales is needed to achieve the optimal relaxation enhancement (Figure 
4.3d). However, recognizing that it could be difficult to change the diffusion coefficient of the 
PFC molecules (constant at a given temperature), an appropriate choice of external field strength 
for imaging would be important to achieve the desired relaxation enhancement effect. Thus, a 
relatively low magnetic field strength would be favored for 19F imaging with paramagnetic PFC 
NP, not only because the longitude relaxation is greater under low field conditions, but also 
because at high field the T2* of the PFC molecule tends to shorten significantly (16).  
 Together, these observations suggested an approach to tracking the function of 
intracellular organelles such as endosomes, based on their expected roles as processors of 
ingested materials.  Upon endocytosis of the PFC NP by professional scavengers such as 
macrophage cells, the paramagnetic PFC NP structures are rapidly unpacked into PFC 
components and separate Gd chelates. This result also explains similar previous experimental 
observations in human umbilical vein derived endothelial cells (45). Because the 19F longitudinal 
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relaxation is highly sensitive to the “distance of closest approach”, in the present study we only 
observed two states for the paramagnetic PFC NP under the time constraints of the data 
sampling: the fully intact form and fully unpacked form. However, in the future, it would be of 
great interest to experimentally observe the dynamic change of 19F T1 during the process of 
endocytosis and then excretion, as a potential novel method for in vitro and even in vivo 
assessment of NP uptake and cellular function. 
 There are several limitations to the proposed model and calculations that are worth 
mentioning.  First, the derivation was based on the theoretic treatment proposed by Solomon, in 
which the zero field split energy has been neglected. Thus, our expression for 1R∆  does not hold 
at low magnetic field when the spin orbit coupling is of the same order at the Zeeman energy. 
Second, we have not considered the radial distribution of PFC molecule on the lipid monolayer 
(46) and the electron relaxation time that might also affect the simulation result (44,47-48). 
Third, although the internalization of Gd chelates was confirmed by intracellular 1H relaxation 
enhancement using cultured cells, neutron activation would provide a more quantitative 
measurement (16). Finally, the shielding effect of the chelate on the Gd electron spin has been 
neglected by assuming the same magnetic moment of Gd ions for DOTA and DTPA.  
Nevertheless, this theoretical framework might be expected to facilitate future chemical 
modifications and applications of such agents with the goal of optimizing their sensitivity and 
utility in clinical molecular imaging with unique, no background, and quantifiable readouts of 
physiological and pathological biomarkers. 
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5 Noninvasive blood oxygenation measurement using 
19F MRI 
5.1 Introduction 
 Blood oxygen tension (pO2) is an essential pathophysiological index of circulatory and 
respiratory health that is useful for characterizing various disorders such as congenital heart 
disease (1), arteriovenous malformations (2), atherosclerotic dysfunction (3),  and overt or occult 
heart failure in general (4). The current gold standard for pO2 measurement entails direct blood 
sampling using arterial puncture, or invasive catheterization when A-V O2 differences, or cardiac 
output and oxygen consumption data are needed.  
 MRI has been exploited as an alternative tool for non-invasive assessment of blood 
oxygenation based on blood-oxygenation-level-dependant (BOLD)  MRI determined 1H R2* (5), 
susceptibility (6), or T2 and T1 contrast (7-8). Among these methods, R2* and susceptibility 
contrast generated by deoxygenated-hemoglobin (deoxy-Hb) can be used to estimate deoxy-Hb 
concentration and blood saturation (SO2) because deoxy-Hb is highly paramagnetic. 
Nevertheless, the readout of BOLD and susceptibility-dependent contrast is qualitative, or 
otherwise requires organ-specific prior knowledge to build complex mathematical models (5-6). 
Blood flow imaging with global T2 preparation has also been employed to measure blood 
oxygenation because of its linear correlation with blood 1H R2.  However, for in vivo studies, B1 
and B0 inhomogeneity and pulsatile flow artifacts pose major obstacles for effective spin 
preparation and consistent R2 estimation (8). Additionally, blood 1H R1 is also linearly 
responsive to dissolved pO2 and thus may also be employed as a quantitative marker for blood 
oxygenation. However, because of the limited solubility of O2 in plasma, the slope of 1H R1 as a 
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function of pO2 is as low as 2×10-4s-1/mmHg, resulting in significant uncertainty for in vivo pO2 
quantification (7).  
 Perfluorocarbon nanoparticles (PFC NPs)  have been proposed as an 19F MR pO2 sensor 
(9-10) as a consequence of  two attributes: (a) O2 is a weakly paramagnetic molecule with 
unpaired electrons and net magnetization; (b) O2 exhibits high solubility in PFC; (c) the linear O2 
release response curve of PFC and the free O2 diffusion between PFC and surrounding 
environment render PFC as a reliable pO2 probe for in vivo applications of measuring vascular 
pO2 (11-12) and tissue oxygenation (9,13-14). Previous reports have demonstrated that the slope 
of 19F R1 of PFC as a function of pO2 could be ten-fold greater than the dependence of 1H R1 on 
pO2 (12-13,15). Additionally, because the lipid monolayer of PFC NPs is impermeable to 
macromolecules and ions, free paramagnetic macromolecules and ions in the blood stream do not 
affect the measurement of 19F R1 emanating from PFC NPs, or its dependency on pO2 (16). 
Finally, as a FDA-approved oxygen delivery vehicle, PFC NPs exhibit an acceptable bio-safety 
profile for ultimate clinical use (17-18). 
 Similar to 1H MRI (19-22), one major obstacle of intravascular pO2 measurements based 
on 19F T1 of PFC NPs is the blood pulsatile motion artifact and in-flow effect. Other limitations 
include relatively low signal-to-noise ratio (SNR) due to limited amount of injected PFC NPs in 
the blood pool, and the inhomogeneity of spin preparation due to the movement of arterial blood 
through a large portion of body during the relaxation measurement. Therefore, the 
implementation of novel 19F MRI strategies to minimize these artifacts would be critical to blood 
pO2 measurements obtained by 19F MRI relaxometry.  
 In the present work, we have first demonstrated the feasibility of imaging blood 
vasculature using 19F MRI of circulating PFC NP. We have developed a novel Blood flow-
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Enhanced-Saturation-Recovery (BESR) sequence for measuring 19F T1 of flowing PFC NPs in 
blood pool. The BESR sequence preserves the time efficiency of the classical Look-Locker 
sequence and the high SNR of saturation recovery sequence. We first performed a computer 
simulation to illustrate the homogeneity of spin preparation in the BESR sequence, and to define 
the effect of limited SNR on the precision of the pO2 measurement. The accuracy of BESR 
sequence measured T1 was tested on a phantom and evaluated in vivo by measuring arterial 1H 
T1 in carotid arteries and cardiac ventricles. Finally, we optimized scan times and PFC NPs 
doses in conjunction with the BESR sequence for 19F imaging of circulating PFC NPs to provide 
a quantitative estimate of arterial and venous pO2 in mouse heart ventricles under both normoxia 
and hyperoxia conditions.  
                        
Figure 5.1 Illustration of the Blood flow-Enhanced-Saturation-Recovery (BESR) sequence. Spin 
preparation is achieved with multiple non-selective saturation pulses; image acquisition uses a 
gradient echo approach with cardiac triggering; saturation pre-pulse train and gradient echo 
imaging are both triggered by ECG. Each image acquisition is acquired at the same trigger delay 
time t but corresponds to different saturation delay time TS. 
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5.2 Material and Methods 
 The BESR sequence was implemented and all images were acquired on a 4.7 T Varian 
INNOVA scanner. All procedures in this study conformed to the guidelines and approvals by the 
Animal Studies Committee of Washington University in St. Louis. 
5.2.1 Blood vessel imaging using 19F MRI of circulating PFC NP 
 A healthy Swiss Webster mouse was anesthetized with ketamine/xylazine followed by 
intravenous injection of 40% v/v perfluoro-15-crown-5-ether (CE) NP (5ml/kg). A 19F gradient 
echo imaging in the transverse plane of the neck region was performed to visualize the blood 
vasculature in this region. Detailed imaging parameters were TR = 500 ms, flip angle = 90±, TE 
= 2.5 ms, thickness = whole projection, in plane resolution = 0.3 mm µ 0.3 mm. Another Swiss 
Webster mouse underwent unilateral carotid artery thrombotic injury induced by FeCl3. The 
aforementioned 19F MRI and conventional 2D time-of-flight 1H angiography were performed to 
evaluate the void of flow at the injured site.  
5.2.2 Pulse sequence and imaging setup 
 The BESR pulse sequence is designed for measurement of pO2 in pulsatile blood flow. It 
is composed of two parts: homogeneous spin preparation and time-of-flight image acquisition 
(Figure 5.1). The spin preparation is achieved with a non-selective whole body saturation pulse 
train and the image acquisition is realized with gradient echoes at high repetition rate. Both the 
pre-pulses and imaging excitation pulses are gated to the ECG with appropriate trigger delay to 
minimize the motion artifact associating with the beating heart and vascular contraction and 
dilation.  
 In contrast to measuring the T1 of solid tissues, the spin preparation for measuring T1 of 
flowing blood should be non-selective and homogenous over the entire subject because spins in 
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the blood that will be excited for imaging might arise from a variety of locations during the spin 
preparation step (22-23). To achieve homogeneous spin preparation, an actively-decoupled 
transmit-only saddle coil (O.D. = 7cm, length = 12 cm) that covers the entire mouse body and a 
composite RF saturation pulse train comprising five constitutive 90± sinc-shaped pulses are 
employed. The bandwidth of each saturation pulse is 12 kHz and the time delay between two 
adjacent saturation pulses is 2 ms, during which crusher gradients are applied along different 
directions. The homogeneity of spin preparation is expected to improve progressively with the 
number of 90± pulses in the saturation pulse train. Specifically, ( , , )s x y z , the percentage residual 
magnetization along z direction in a voxel positioned at ( , , )x y z  after n closely spaced saturation 
pulses followed by crusher gradients can be written as  
( , , ) [cos( ( , , ))]ns x y z x y zϕ= ,           [1] 
where ( , , )x y zϕ  is the flip angle at ( , , )x y z  and is determined by the 1B  field profile according 
to 1( , , ) ( , , )x y z B x y zϕ τγ= , where γ  is the Larmor frequency and τ  is the pulse width. To 
confirm the homogenous saturation over the region of interest (ROI), we first acquired a flip 
angle mapping of our transmit coil on a water phantom (D = 6 cm, length = 10 cm) using a dual 
angle B1 mapping approach with α = 30± (24). Quantitative residual magnetization mapping after 
various number of saturation pulses (NSP) was then obtained by adjusting NSP in the BESR 
sequence. 
 In traditional 1H saturation recovery T1 mapping, only one imaging excitation pulse is 
allowed within a single TR to avoid partial saturation effects arising from frequent repetitive 
excitations (25). In contrast, because of relatively fast blood flow in major blood vessels (>1 
cm/s) and the “time-of-flight” effect, we anticipate that excited spins in the previous echo will 
flow out of the imaging slice as long as the time interval between two temporally adjacent 
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excitation pulses is sufficiently long (e.g., >0.2 s for 2 mm slice). Within a single TR of the 
BESR sequence, multiple 90± excitations, each followed by a same phase encoding gradient, are 
applied for gradient echo imaging. Thus, all echoes acquired in a single TR correspond to the 
same k-space line at different saturation delays (TS). All the imaging excitation pulses are 
synchronized with the ECG to minimize the effect of heart rate variations during imaging (26). 
Finally, to achieve an optimal SNR with BESR sequence, a dedicated actively-decoupled 
receive-only surface coil (diameter ≈ 3 cm) is placed close to the region of interest for signal 
reception.  
5.2.3 Estimating the effect of SNR on the accuracy of pO2 measurement 
 The uncertainty of the pO2 estimation caused by random noise in saturation recovery 
imaging was evaluated using computer simulations in Matlab (Mathworks, USA) and 
conventional saturation recovery imaging on PFC NPs phantoms. A region of interest (ROI) 
containing 100 pixels was defined to simulate the number of pixels in heart ventricles. Normally 
distributed Gaussian noise was imposed on the 19F signal intensity in each pixel to achieve 
variable SNR. The average noise-contaminated signal in entire ROI was used for non-linear 
fitting of T1 values. The conversion between T1 and pO2 values was based on the pre-acquired 
calibration curve. In the simulation, the following saturation delays were used:  TS = 0.25, 0.5, 
0.75, 1, 1.25, 1.5, 1.75, 2 and 10 s. Simulation was repeated 10000 times and the standard 
deviation of the fitted pO2 was calculated to represent the measurement uncertainty propagated 
from imaging noise through non-linear fitting. For phantom imaging, three PFC NPs phantoms 
with volume concentration of 5%, 10% and 20% were sequentially bubbled with N2, room air 
and O2 for 10 minutes. The phantom temperature was maintained at 37°C with a circulating 
water bath. A saturation recovery fast spin echo sequence was used for T1 mapping: TR=3 s, 
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FOV=25 cm × 25 cm, TE = 8.6 ms, echo train length = 16, Matrix size=128 × 128. The standard 
deviation of the fitted pO2 values for each single pixel was used to calculate the uncertainty of 
pO2 estimate in an ROI containing 100 pixels.  
5.2.4 In vitro and in vivo validation of BESR sequence 
 The accuracy and precision of the BESR sequence was tested by measuring 1H T1 of 
circulating water in a tube phantom, which simulated the in vivo setting of 19F MRI with all 
signal contributed only by intravascular PFC NPs devoid of tissue background. Briefly, 
approximately 80 cm silicon tubing (1/8” inner diameter) was twisted and coiled to form an 8-cm 
long phantom with multiple loops. The phantom was then connected to a pump to generate 
constant 5 cm/s flow velocity to mimic blood flow. The special design of the phantom together 
with the carefully chosen flow velocity simulate the blood flow situation in vivo, such that the 
flowing water could experience a homogenous spin preparation at the beginning of each TR (5 s) 
, but is moving rapidly enough to generate the desired “time-of-flight” effect to replenish the 
imaging slice with unexcited spins before each gradient-echo (10 echoes in each TR ranging 
from 0.1 s to 4.6 s time interval between consecutive imaging acquisitions = 0.5 s). Upon the 
completion of BESR measurement, the pump was turned off and the 1H T1 of stationary water 
was measured with a saturation recovery fast spin echo sequence. The image parameters of fast 
spin echo were TR=5 s, TE = 8.6 ms, echo train length =16, TS=0.1 to 4.6 s with intervals of 0.5 
s.  
 To confirm that the BESR sequence can achieve reproducible T1 measurements in vivo, 
1H T1 measurements of flowing arterial blood in carotid arteries and heart ventricles were 
acquired in Swiss Webster mice (n=5) at 4.7 T. Mice were anesthetized through inhalation of 
1.5% isoflurane ventilated by pure O2  (2 L/min). Body temperature was maintained at 37°C and 
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ECG was monitored with a small animal monitor system (SAI Inc., USA). During MRI, the 
isoflurane level was adjusted to maintain mouse heart rate at around 350 bpm. Imaging 
parameters were: TR=2.5 s, TE = 2.8 ms, FOV=25 cm×25 cm, matrix size=96×96 and number of 
TS=7. After in vivo imaging, mice were sacrificed and blood was collected from LV. T1 of the 
collected stationary blood was measured using a custom-built solenoid coil and traditional 
inversion recovery spectroscopy at 37°C after saturating with pure O2. 
5.2.5 PFC NP formulation and in vitro T1 calibration 
 Perfluoro-15-crown-5-ether (CE) nanoparticles were formulated as previously described. 
Briefly, the CE emulsion was composed of 40% (v/v) of CE (Exfluor Research Corp., USA), 
2.0% (w/v) of a surfactant commixture, and 1.7% (w/v) glycerin, with water comprising the 
balance. In vitro calibration of 19F R1 as a function of pO2 was performed at three different O2 
concentrations (0%, 21%, and 100% O2  balanced with N2) by bubbling gas mixture into a CE 
emulsion sample for 30–60 min at both room temperature and 37°C. 19F T1 measurements were 
made using inversion recovery spectroscopy with TR=10 s, and 10 inversion delays (TI) ranging 
from 3 ms to 5 s. To confirm that the linear response curve of CE NP on pO2 was preserved in 
the blood, mouse blood (Bioreclamation, LLC, USA) containing 10% volume/volume ratio of 
CE NP was placed in a gas chamber to allow gas exchange through semi-permeable silicon 
tubing for 30 minutes.  Blood was transferred to a sealed vial and the sample temperature was 
maintained at 37°C. For the linear fitting, the conversion of partial percentage of oxygen to 
mmHg was based on the assumption that 100% oxygen is equivalent to 713 mmHg (considering 
the vapor pressure at 37°C is 47 mmHg). 
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5.2.6 Noninvasive intravascular pO2 measurement with BESR 19F imaging  
 Swiss Webster mice (n=5) were anesthetized with 1-2% isoflurane mixed with room air 
or O2 followed by intravenous injection of CE NP (5 ml/kg) via the tail vein. The 19F signal from 
isoflurane was barely detectable by MRI in contrast to the strong 19F single emanating from CE 
NP in the blood stream, which is likely due to low blood/tissue retention and the short T2* of 
isoflurane (27).1H gradient-echo cine images were acquired initially to position the slices to 
cover both left and right ventricles (LV and RV).  Blood 19F T1 measurements were carried out 
under separate conditions of room air and then pure oxygen ventilation. The saddle coil and the 
surface coil were re-tuned as needed to the proper frequency of  201.5 MHz and 189.6 MHz for 
1H and 19F imaging, respectively. Parameters for 19F BESR T1 measurement were:  TR, 2.5 s; 
TE, 2.2 ms; number of points along recovery curve, 8; number of averages, 16; in plane 
resolution, 1.5 mm × 0.75 mm; slice thickness, 2 mm. In order to optimize non-linear fitting for 
19F T1 of less-oxygenated venous blood exhibiting T1 > 2 s, another set of BESR images 
acquired with identical imaging parameters but without pre-saturation pulses were used as fully 
recovered signal. The previously measured 19F R1 vs pO2 calibration curve was used for 
quantifying intravascular pO2 in vivo.  
5.2.7 Data analysis and statistics 
 The left and right ventricles and vessel lumen were manually segmented on 1H and 19F 
images. ROI was defined as the region exhibiting > 3 SD higher 19F signal intensity, i.e., signal 
contributed by PFC NPs in the blood, as compared with that of surrounding tissues. The average 
intensity in each ROI was used for fitting data to a 3-parameter saturation recovery curve: 
1/( ) TS TS TS A Be−= − .        [2] 
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 All statistical analysis was performed using Origin software (OriginLab, USA). Metrics 
for precision and accuracy of T1 measurements with the BESR sequence were assessed based on 
1H image of the tubing phantom. The precision error was calculated as the root-mean-square of 5 
individual measurement normalized by the mean value, and the accuracy error was considered to 
be the relative difference between the T1 mean value measured using a reference method and the 
BESR sequence. A two sample paired t-test was used for statistical analysis to test the difference 
between BESR measured 1H T1 values and reference 1H T1 values in vivo, and the difference of 
19F MRI determined pO2 between hyperoxic and normoxic conditions. A significance threshold 
of p < 0.05 was used for hypothesis testing.   
 
Figure 5.2 Saturation profile of saturation pulse train of BESR sequence. (a, b) Flip angle 
mapping of a water phantom in axial and coronal plane. (c, d) Measured residual magnetization 
after different number of saturation pulses (NSP = 1, 3, 5) in axial and coronal plane. The yellow 
dashed lines represent the border of the ROI for in vivo study. The residual magnetization inside 
the ROI is presented as mean ≤ standard deviation.  
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5.3 Results 
5.3.1 Measurement of the homogeneity of pulse train saturation 
 The flip angle mapping of the transmit coil and the percentage residual magnetization 
intensity after different number of saturation pulses (1, 3, and 5) were measured experimentally 
and shown in Figure 5.2. As the number of saturation pulses increased, spin nulling in the whole 
FOV became more uniform despite the inhomogenity of the B1 profile. After five consecutive 
90± pulses, the residual magnetization within the ROI where mice were placed for in vivo 
experiments (border marked by yellow dash line) was < 4%, substantially lower than the > 20% 
residual magnetization after a single saturation pulse.  
5.3.2 19F MRI of PFC NP in the blood pool 
 PFC NP in blood vessels at the neck region was readily visualized using 19F MRI (Figure 
5.3). The angiograms generated from whole projection of 19F MRI and maximal intensity 
projection (MIP) of 1H angiography automatically co-registered with each other. Void of blood 
flow in the left carotid artery caused by the external injury was detected by both 19F and 1H 
angiography. It is notable that compared to 1H MIP, 19F angiography features a non-background 
delineation of blood vasculature.   
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Figure 5.3 19F angiography in mouse. (a) shows a “maximal intensity projection” of the 1H and 
19F angiograms at the neck of mouse, where blood vessel geometry is clearly depicted. The 
thrombus site in the carotid artery is visually appreciable in 19F angiography (b), which is 
consistent with the time-of-flight 1H imaging (c). 
5.3.3 Validation of BESR sequence determined T1 
 The 1H T1 measured in the tube phantom and in arterial blood flow is summarized as 
follows: BESR sequence determined 1H T1 of circulating water (2.96 ≤ 0.43 s) was comparable 
to that of stationary water measured with a traditional saturation recovery sequence (3.30 ≤ 0.17 
s, N.S.). The precision and accuracy errors were 13.0% and 10.3%, respectively. The precision 
and accuracy errors provide quantitative estimates for the potential measurement bias and 
uncertainty, respectively. The in vivo measured 1H T1 in arterial blood (on 100% O2) in left and 
right carotid arteries and left ventricle were 1.62 ± 0.12 s, 1.59 ± 0.2 s, and 1.67 ± 0.14 s, 
respectively. The corresponding in vitro T1 of sampled arterial blood saturated with 100% O2 
was 1.78 ± 0.18 s (N.S. compared to all in vivo measurements).  
5.3.4 In vitro calibration of 19F R1 as a function of pO2 
 In vitro measurements validated the linear dependence of 19F R1 on pO2 (Figure 5.4). At 
37±C, 
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1
21( ) (0.396 0.014) (0.0024 0.0003) ( )R s pO mmHg− = ± + ± × .     [3] 
Deoxy-Hb did not exhibit any observable paramagnetic relaxation enhancement effect on 19F T1, 
because 19F R1 vs pO2 curve was identical in aqueous solution and mouse blood.  
                         
Figure 5.4 Calibrated linear relationship between 19F R1 and pO2 at room temperature and 37±. 
The calibration curve at 37± is used for the in vivo study. Error bars represent standard deviation.  
5.3.5 In vivo measurement of blood oxygenation 
 Figure 5.5 shows representative BESR images of a mouse heart under hyperoxia and 
normoxia. After spin saturation, blood in the left ventricle (LV) exhibited a faster recovery of 
signal intensity than that in the right ventricle (RV), which was further accelerated when the 
mouse was breathing pure O2 (i.e., hyperoxia). The fitted 19F R1 confirmed the faster relaxation 
of the more oxygenated blood. Based on the calibrated correlation between 19F R1 and pO2 (Eq. 
3), 19F MRI-measured LV blood pO2 was 458 ≤ 133 mmHg under hyperoxia and 96 ≤ 21 mmHg 
under normoxia; significantly higher than RV blood pO2, which was 103 ≤ 21 mmHg under 
hyperoxia and 49 ≤ 15 mmHg under normoxia (Figure 5.6, p < 0.05 for all comparisons).  
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Figure 5.5 In vivo 19F BESR MRI of heart ventricles. (a) A short-axis 1H image shows the left 
and right ventricles. (b) 19F BESR images of the same mouse heart under hyperoxia and 
normoxia. (c-d) Fitted 19F saturation recovery curve for LV and RV blood under normoxia and 
hyperoxia. Error bars represent standard deviation. 
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Figure 5.6 Ventricular pO2 estimated using BESR sequence. Measured blood pO2 based on 
measured 19F T1 of PFC NPs showed pO2 difference between LV and RV, and between 
normoxic and hyperoxic conditions for each ventricle, *, p<0.05. 
5.3.6 Accuracy of pO2 measurements at different SNR 
 Since low SNR is a common problem in 19F MRI, the effect of SNR on 19F BESR 
determined pO2 was evaluated by mathematical simulation (Figure 5.7).  As expected, the 
accuracy of 19F MRI measurements of pO2 increased with SNR. However, the pO2 measurement 
was less susceptible to noise (in the sense of absolute measurement uncertainty) at lower oxygen 
tension. When image SNR = 9, the measurement error of 19F MRI determined pO2 was <10 
mmHg under hypoxic condition (pO2 <50 mmHg) and <40 mmHg under hyperoxic condition 
(pO2 > 500 mmHg). Phantom studies with varying concentrations of PFC NPs (Figure 5.7b) 
confirmed the simulation result. Higher imaging SNR substantially reduced the uncertainty and 
increased the precision of the 19F R1 measurements.   
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Figure 5.7 Effect of SNR on the accuracy of pO2 measurement. (a) Simulation result shows 
measurement accuracy improves as SNR increases. pO2 measurement uncertainty is higher under 
hyperoxic condition. (b) Measured pO2 for three PFC NPs samples with different NP 
concentration bubbled with N2, Air and O2, respectively. The mean value of measured pO2 is 
independent of PFC NPs concentration but measurement uncertainty (error bars) is suppressed 
by increased SNR.  
 
5.4 Discussion 
 In the present work, we experimentally demonstrated the feasibility of 19F angiography in 
mouse. We have implemented a novel BESR sequence to quantify blood pO2 based on 19F R1 of 
circulating PFC NPs. Because 19F R1 of PFC NPs is not affected by the paramagnetic effect of 
deoxy-Hb and manifests a linear association/release curve as a function of dissolved [O2], it 
represents a promising probe to quantify blood pO2. Our results demonstrate that the BESR 
sequence: 1) achieves a consistent T1 measurement for pulsatile blood flow, 2) differentiates 
blood pO2 in the LV and RV, and 3) depicts the response of ventricular blood oxygenation to 
hyperoxic challenge.  
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 One concern regarding the use of any oxygen sensing probe in vivo is whether other 
molecules or ions will affect the chemical properties of the probe. In this study, we observed that 
pO2 - 19F R1 relationship remained unchanged for PFC NPs in salt solution and blood sample. 
This is consistent with our previous findings that 19F R1 of PFC NPs is not affected by 
surrounding free paramagnetic ions (16,28) since their direct interactions are prevented by the 
lipid monolayer of PFC NPs, which is permeable to O2 but not to macromolecules. The observed 
linear pO2 response curve of PFC NP agreed with that observed in previous reports despite the 
difference in the fitted coefficient at different magnet field strength (12,29-30).The observed 
temperature dependence of 19F R1 has also been previously reported (15).  
 The long circulating half life time of PFC NPs and high 19F spin density are advantageous 
to use PFC NPs as a blood pool pO2 probe. The mean half life of PFC NPs in the blood plasma is 
~180 minutes in mouse and even longer in humans (31). Thus, the slow clearance of 
intravascular PFC NPs allows a relatively wide temporal window for quantitative pO2 
assessment with 19F MRI. In addition, even though PFC has high affinity for O2, the modest 
administered dose is small enough such that the total amount of dissolved O2 carried by PFC NPs 
is orders of magnitude less than that carried by plasma and red blood cells (dissolved plus oxy-
hemoglobin) (32-34). Therefore, the blood-pool PFC NPs acted as a pO2 sensor rather than a 
primary O2 reservoir and the 19F MRI measured pO2 values reflects pO2 in blood stream.  
 In major arteries (or ventricles), and veins, the velocity of blood flow is > 10 cm/s and 1 
cm/s, respectively. For a typical imaging slice thickness (1-2 mm), the minimal time required for 
blood to flow through the slice is approximately 100-200 ms. By setting the time interval 
between two consecutive excitation pulses greater than 200 ms and selecting imaging slices 
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perpendicular to the flow direction, the previously excited spins should not affect the subsequent 
image acquisitions. Thus, gradient echo imaging with 90± excitation pulses can achieve maximal 
SNR without partial saturation effects. On the other hand, because the blood flow is rapid in 
major blood vessels, during the recovery process of the T1 measurement the real “imaged” spins 
within the region of interest may originate from distant locations. This requires homogeneous 
spin pre-saturation over a large volume of the imaged subject. Consistent with previous studies 
that utilized pre-saturation pulse trains (33,35), our result suggests that a non-selective saturation 
pulse train with crusher gradients was robust for reducing both B0 and B1 inhomogeneity while 
achieving a satisfactory uniform spin saturation profile. By implementing multiple saturation 
recovery acquisitions in each TR, the BESR sequence achieved higher SNR than traditional 
saturation recovery or inversion recovery T1 measurement sequences.  
 The novelty of BESR resides in the utilization of a homogenous RF pre-saturation and a 
train of ECG gated excitation/readouts in a single TR for fast T1 quantification. Due to the 
refreshing of intravascular PFC NP in the imaging slice ( thickness = 2 mm) between adjacent 
heart beats, the acquired blood-pool 19F signal by each readout directly represents the 19F T1 
recovery at corresponding delay times after saturation. In contrast, the conventional saturation 
pulse sequence only acquires one echo after each RF saturation, and the different T1 recovery 
weighting is achieved by varying TR (36). Thus, the BESR sequence provides a faster imaging 
method for quantifying blood 19F T1 by taking advantage of the time-of-flight effect of blood-
flow in conjunction with intravascular PFC NP contrast agent. Although multiple 90± pulses 
were used in this study, other pulse shapes such as adiabatic or composite pulses also could be 
employed as long as homogeneous whole-body saturation is achieved (37). Similarly, fast 
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imaging techniques like EPI could replace the single echo to further accelerate image acquisition 
(36).  
 The BESR sequence is optimized for 19F MRI because: (a) the PFC NP is an 
intravascular agent; (b) there is no 19F background in soft-tissue; (c) O2 dissolving and release 
from PFC NP (~250 nm) operates through free diffusion that occurs in milliseconds (38). In 
capillaries, the measured pO2 may directly reflect tissue pO2  if the O2 exchange between tissue 
and microvasculature is rapid (39). In ventricles and major blood vessel that experiencing no 
blood-tissue O2 exchange, the measured pO2 would represent venous or arterial blood pO2. 
Finally, although the BESR sequence could be applied to quantify 1H T1 in blood pool, the small 
correlation coefficient between 1H R1 and pO2 may be problematic for accurate pO2 
determination. Additionally, the O2 release response curve of hemoglobin is non-linear, therefore 
the accuracy of 1H MRI measured blood pO2, as well as its relationship with tissue pO2, remains 
to be defined.     
 The proposed 19F imaging methodology has direct translational potential. The technique 
might be readily adapted to evaluate arteriovenous pO2 difference for selected organs, e.g. renal 
arteries and veins for kidney, carotid arteries and jugular veins for brain, aorta and coronary 
sinus for heart, among others. Further integration of 19F MRI determined A-V pO2 with phase-
contrast 1H or 19F MRI determined blood flow velocity may enable assessment of oxygen 
consumption in individual organs as a critical pathological marker for evaluating injury at a 
cellular level.  
 Based on the accuracy profile of 19F-determined pO2, imaging noise significantly affects 
the measurement uncertainty of pO2 through non-linear T1 fitting. Therefore, the acquisition of 
19F images with sufficient SNR is crucial to accurately estimate intravascular pO2, which also 
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was reported previously by Barker et al (14). In the present study, all images exhibited SNR > 7, 
and according to our simulation (Figure 5.6a), pO2 estimates from these images could achieve a 
measurement uncertainty as low as 10 mmHg under normoxia and 30 mmHg under hyperoxia 
depending on real pO2.      
 Several limitations of the current pO2 measurement paradigm should be mentioned. Even 
though the blood flow in major blood vessels is fast enough to create “time-of-flight” 
phenomenon, the velocity profile of blood flow is laminar, where the velocity close to the blood 
vessels walls is virtually zero. This portion of the blood may contribute to 19F signal resulting in 
reduced accuracy of pO2 measurement in such regions (22).  In the cardiac ventricles and major 
vessels, non laminar blood flow (e.g., turbulence) also may cause errors in T1 estimation due to 
spin de-correlation, which is not unexpected and can be visualized on 1H images for proper data 
interpretation (40). Because the ejection fraction of normal ventricle is around 60%, after two 
heart beats around 16% residual blood still remains in the same ventricle. The residual blood 
may suffer from partial saturation from previous excitation and cause errors in T1 measurement. 
The systematic error (about 6% of T1 measured in phantom experiments) caused by these factors 
may be corrected by flow dynamical modeling in the future. The relative error of 19F BESR MRI 
determined blood pO2, (i.e., 50 mmHg) in well oxygenated arterial blood or in venous blood (10 
mmHg), could limit the application of this technique for measurement of tumor oxygenation, but 
there are other uses that offer insights into myriad pathophysiologies. Finally, for human 
imaging, where sampling once per cardiac cycle is too slow because of lower heart rate, the 
sequence should be modified to image more than once per cardiac cycle. 
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6 Functional 19F renal MRI 
6.1 Introduction 
 In healthy kidneys, the countercurrent design of blood vessels and tubules maintains the 
necessary osmolar gradient to permit efficient urinary concentration, yet the system operates 
under conditions of a relatively hypoxic environment in some regions requiring extensive 
extraction of oxygen from flowing blood (1-4). During acute and chronic kidney injury, ischemia 
further hampers effective O2 delivery to the capillary bed of renal tubules, as extraction of extra 
oxygen is marginal, resulting in exquisite susceptibility to ischemic damage to the renal medulla 
culminating in renal failure, hypertension from chronic kidney disease, and even death (5). 
Because acute kidney injury (AKI) is increasing in the hospitalized patient population, the 
development of quantitative and repeatable measurements of renal circulatory function (e.g. 
blood volume, perfusion, and regional oxygen tension) could enhance pathophysiological staging 
of the early disease process and its response to therapy (6). To this end, we sought to design and 
implement multiparametric quantifiable noninvasive imaging approaches that avoid the use of 
nephrotoxic contrast agents. 
 The current standard approaches for imaging renal perfusion entails bolus injection of 
exogenous contrast agents (e.g. iodinated compounds for CT, gadolinium chelates for MRI, etc.) 
following by a series of image acquisitions (e.g. X-ray, SPECT, PET, MRI) to capture the first-
pass dynamics of contrast agents flowing through the kidney (7-9). Despite the general 
acceptance of these methods, heightened concern persists regarding their application in patients 
with potentially compromised kidney function (10). Indeed, the potential for contrast-induced 
nephropathy that can dramatically accelerate renal damage calls for great caution or even 
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avoidance of their use in the patients with acute and/or chronic kidney disease (11-14). Even 
with the use of gadolinium agents formerly thought to be devoid of such toxic side effects, slow 
and incomplete clearance can enhance susceptibility to untreatable conditions such as 
nephrogenic systemic fibrosis (15-16). Over the past two decades, the development of 
noncontrast MRI techniques has lead to promising new image-based measures of kidney function 
(17-19). Among these, Blood-Oxygenation-Level-Dependent (BOLD) MRI has demonstrated 
potential for correlating intrarenal oxygenation with 1H susceptibility (T2*) measures (20).  
Arterial Spin Labeling (ASL) MRI also has been touted as a clinically available technique for 
defining renal perfusion without the need for exogenous contrast media (21). However, the lack 
of widespread adoption of available BOLD and ASL MRI methods raises questions as to their 
ultimate clinical utility (22-24).  
 Alternatively, Perfluorocarbon (PFC) based Nanoparticles (NPs) are a class of clinically 
approved vehicles recently applied in vivo for targeted molecular imaging and non-invasive 
oxygen tension (pO2) assessment (25-26). As compared with iodinated or Gd contrast agent, PFC 
NPs may be especially suited to patients with kidney disease. As approved blood substitutes, 
PFC NPs are biologically inert and exhibit a good safety profile with no renal toxicity reported in 
both animals or human (27). Because PFC NPs (nominal size = 250 nm) are not cleared through 
glomerular filtration (28), they do not increase kidney workload, which is a major risk factor for 
kidney failure with other agents that undergo renal clearance (14). For imaging purposes, the 
unique 19F MR signal emanating from the fluorine core of PFC NPs can be measured directly in 
vivo in rather sparse concentrations (picomolar) with no background signal as might be the case 
for other paramagnetic or superparamagnetic moieties that exert indirect contrast effects on 
circulating protons (29-30). PFC NPs have been demonstrated as effective functional probes for 
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both blood volume and pO2 determination. Specifically, the detected 19F signal intensity directly 
reflects the actual quantity of PFC NPs within a voxel. Furthermore, the 19F longitudinal 
relaxation rate (R1) responds directly to local oxygen content in a linear manner (31-32).  
 Inflammation-coagulation interaction induced capillary non-perfusion is a primary 
pathology of AKI (33). Inflammation activates coagulation through three major pathways: 
thrombin generation mediated by tissue factor; fibrin deposition after fibrinolysis inhibition; and 
down-regulation of the protein C. The pro-coagulant effect could be further enhanced by the 
activated platelets (34-36).  PPACK is a potent anti-coagulation agent that inhibits thrombin 
activation and interrupts fibrin formation (36). The binding of PPACK-thrombin complex to 
platelets inhibits their activation. We have recently demonstrated that PPACK loaded PFC NPs 
could function as an in vivo anti- coagulation agent that effectively delays arterial thrombosis in 
mice (37).  
 The objective of this study is to develop a 19F MRI contrast paradigm for functional renal 
imaging.  Here we demonstrate in healthy kidneys the feasibility of using 19F MRI to directly 
register renal blood volume (RBV) and intrarenal oxygen tension pO2. As compared with BOLD 
and ASL MRI, the19F MRI method requires no model-based assumptions for absolute 
quantification of renal physiological indexes. To evaluate the diagnostic capability of kidney 19F 
MRI, we tested the approach in an established mouse model of ischemia-reperfusion AKI (38). 
Based on the results, we propose that the functional readouts generated by 19F MRI in concert 
with PFC NP, alone or perhaps combined with traditional BOLD MRI, could facilitate 
comprehensive quantitative assessment of micro-circulatory status in AKI.  
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6.2 Material and Methods 
 All procedures, including treatment, MRI imaging and animal surgery, in this study 
conformed to the guidelines of and with the approval of the Animal Studies Committee of 
Washington University in St. Louis. 
6.2.1 Nanoparticle formulation and calibration of 19F R1 vs pO2 
 Perfluoro-15-crown-5-ether (CE) nanoparticles (NPs) were formulated as previously 
described (30). Briefly, the CE emulsion was composed of 40% (v/v) of CE (Exfluor Research 
Corp., USA), 2.0% (w/v) of a surfactant commixture, and 1.7% (w/v) glycerin, with water 
comprising the balance. CE NP was also co-labeled with Alexa Fluor 594 to enable ex vivo 
fluorescence microscopy examination. In vitro calibration of 19F R1 as a function of pO2 was 
performed at three different O2 concentrations (0%, 21%, and 100% O2 balanced with N2) by 
bubbling gas mixtures into a CE emulsion sample for 30 minutes at 37°C. 19F T1 measurements 
were made with inversion recovery spectroscopy at TR=10 s, with 10 inversion delays (TI) 
ranging from 3 ms to 5 s. 
6.2.2 In vivo 19F and BOLD MRI of kidney 
 Mice were anesthetized with a continuous intramuscular infusion of ketamine/xylazine. 
Body temperature was monitored and maintained at 37 ≤ 1°C during the MRI scans with the use 
of a small animal monitoring system (SAI Inc., USA) and a feedback controlled heated fan 
system. Mice were restrained in a custom-built holder and allowed to breathe pure oxygen 
through a nose cone. The respiratory signal was acquired from additional tubing connected to the 
nose cone and used as the gating trigger for in vivo imaging.  
 All in vivo imaging was performed on an 11.7 T Varian scanner with a custom-built 
actively decoupled coil pair. The transmit coil (5 cm by 10 cm) was built to cover the entire 
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imaging field of view, and optimized for superior field homogeneity and power transmit 
efficiency. Mice were imaged in a supine position and the surface receive coil (1 cm by 2 cm) 
was adjusted to match the mouse body curvature. Because of the strong magnetization 
originating from the high field strength, the 1H signal was sufficient to generate high quality 
anatomical image within a minimal scan time (< 5 minutes) despite being slightly off-resonance. 
Thus, both transmit and receive coils were tuned and matched at 19F frequency for both 19F and 
1H imaging. 
 Before in vivo MRI, 0.1 mL (~ 5mL/Kg) CE NP was administrated intravenously through 
the tail vein. A 1H gradient echo sequence was employed to locate the region of interest (ROI) 
followed by a 1H multi-echo gradient echo BOLD scan with: TR = 100 ms, TE = 1.96 ms with 
1.75 ms increment for every echo, flip angle = 10°, field of view = 26 mm × 26 mm, voxel size = 
0.2 mm × 0.2 mm × 2 mm. Two sets of 19F MRI scans (spin density weighted and T1-weighted 
images) were performed using a respiration-gated fast spin echo sequence. TR was set to 4 s for 
the spin density weighted 19F MRI whereas the TR was set to two respiration periods for the T1-
weighted imaging. All other imaging parameters are identical in these two sets of 19F MRI: ETL 
= 4, TE = 11.5 ms, receive bandwidth =20 kHz, voxel size =  0.4 mm × 0.4 mm × 2 mm, and the 
field of view identical for 1H scout and BOLD imaging.  
6.2.3 Quantification of renal blood volume and intrarenal pO2 (n = 5) 
 In order to quantify intrarenal blood volume and oxygenation, an external standard with 
known concentration of CE NP was placed at the edge of animal holder for all in vivo 19F 
imaging. The CE NP reference comprised [ ]stdNP =5 ml/L CE in agarose gel to avoid NP 
aggregation. We performed spatial sensitivity mapping of the RF coils on a saline phantom 
placed into the mouse holder and positioned at the intended imaging location. The imaging 
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parameters were: TR = 100 ms, TE = 1.96 ms, and flip angle = 10°. The phantom image 
provided a pre-determined correction factor ( , , )R x y z , which was the inverse of the absolute 
signal, to normalize all in vivo measured 19F signal intensities, which compensated for the effect 
of sensitivity profile inhomogeneity on received signal (39).  
 Immediately after in vivo 19F imaging, blood was drawn from the left ventricle and the 
blood sample was placed beside the external standard for ex vivo 19F imaging using a custom-
built 19F solenoid coil. The average signal intensity ratio between the blood sample and external 
standard offered a direct measurement of the CE NP concentration in the circulating blood 
[ ]bloodNP  (ml/L). The detailed scan parameters for ex vivo imaging were identical to the spin 
density weighted 19F MRI in vivo.  
 By combining ex vivo calibration and in vivo 19F MRI, we calculated the renal blood 
volume (% of voxel volume or tissue weight) in each imaging voxel based on the following 
equation:  
0 0 0 0 0 0
( , , ) ( , , ) [ ]( , , ) ( , , ) ( , , ) [ ]
long std
long blood
S x y z R x y z NP
RBV x y z
S x y z R x y z NP
× ×
=
× ×
,                                         [1] 
where ( , , )longS x y z  and 0 0 0( , , )longS x y z  are the signal intensities at the kidney and the external 
standard in the 19F spin density weighted images. ( , , )R x y z  and 0 0 0( , , )R x y z are the correction 
factors at the location of kidney and the external standard. 
 In vivo renal T1 quantification and pO2 measurement were based on the fundamental 
assumption that image signal intensity in a fast spin echo sequence depends on TR and follows a 
saturation-recovery process: 
/ 1
0( ) (1 )TR TS TR S e−= − ,        [2] 
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where 0S  is a TR-independent baseline parameter. Such a formalism is accurate to the first order 
when TE << TR in a fast spin echo sequence (40). In the present study, TR for spin density and 
T1-weighted images were 4 s and ~1 s respectively (or ~400 and ~100 times longer than TE = 
11.5 ms, respectively). Therefore, Eq. [2] was applicable for approximating the signal intensity 
in renal 19F images. 
 Because T1-weighed 19F MRI was gated with respiration, the real TR might vary from 
animal to animal. Therefore, the real TR was determined retrospectively from the ratio of the 
signal intensities of the external standard in the spin density weighted 19F MRI and T1-weighted 
19F MRI in vivo: 
0 0 0
t
0 0 0
( , , )1 ln( )( , , )
short
short s d
long
S x y zTR T
S x y z
= − × ,    [3] 
where t1s dT is the 
19F T1 in the external standard that is directly measured in vitro, 
0 0 0( , , )shortS x y z  and 0 0 0( , , )longS x y z  are the signal intensities of the external standard in T1-
weighted and spin-density weighted 19F MRI. Here we also accounted for the fact that in the spin 
density weighted image, TR > 4 s could be assumed to be sufficiently long that there was no T1 
effect in this image because it was over 3 times longer than the normal 19F T1 in kidneys. With 
real TR acquired from external standard, voxel-wise T1 mapping of the kidney could be 
calculated as  
1( , , )
ln( ( , , )) ln( ( , , ))
short
long short
TRT x y z
S x y z S x y z
=
−
.   [4] 
Finally, T1 values were translated into corresponding pO2 levels according to the pre-determined 
calibration curve relating 19F relaxation and oxygen tension.  
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6.2.4 Mouse acute kidney injury (AKI) model 
 C57/Bl mice (n=10) underwent laparotomy and a standard procedure to produce warm 
ischemia-reperfusion injury (41). Briefly, mice were anesthetized with ketamine/xylazine 
followed by a mid-line incision on the abdomen. After exposing the vasculature of the left 
kidney, we induced ischemia by ligating both renal artery and vein with a suture. Cessation of 
renal blood flow and restoration of perfusion after releasing the ligatures were confirmed 
visually by noting the color change of the kidneys. Mice with incomplete ischemia or reperfusion 
were excluded prospectively from the study. Ischemia was maintained for 60 minutes, during 
which mice were kept warm with a water-circulating blanket at 37±C. To avoid dehydration of 
exposed organs, warm saline was added to the abdominal cavity during ligation. 24 hours after 
surgery, both injured and contralateral kidneys were scanned with functional 19F and BOLD MRI 
in vivo as described previously. After in vivo MRI, 10 µl FITC-lectin (Vector Laboratory, USA) 
was injected into the left ventricle and allowed to circulate for 5 minutes. Both kidneys were 
harvested and frozen in OCT media (Tissue-Trek, Japan) for fluorescence microscopic imaging 
and histological preparation.   
6.2.5 Histology and fluorescence imaging 
 Frozen tissues were sectioned into 8 µm slices for histology and fluorescence imaging. 
Briefly, hematoxylin and eosin were used to stain kidneys to confirm tissue damage caused by 
ischemia-reperfusion. Fluorescence images were digitized with an Olympus BX61 fluorescent 
microscope after mounting with DAPI mount media (Vectashield Inc., USA). DAPI, Texas Red 
and FITC channels were selected to image the nucleus, CE NP, and perfused blood vessels 
respectively. All fluorescence images were color coded and co-registrated in IMAGEJ (NIH, 
USA). 
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6.2.6 Treatment evaluation for PPACK NPs in AKI 
 PPACK NPs was prepared using our previously described protocol to achieve an average 
loading of 13,650 PPACK on each particle. Animals were injected with PPACK NPs (N = 3) or 
plain NPs (N =3) at 15 minutes before experiencing 45 minutes ischemia (dose: 1 mL/Kg). At 3-
hour after reperfusion, animals were euthanized and perfused with saline to washout blood-pool 
NPs in perfused vessel. Ev vivo spectroscopic quantification of retained NP concentration was 
performed using a standard single pulse 19F spectroscopy sequence and a sample of 10 µl 
trifluoroacetic acid (TFA, 0.1% volume concentration) as external reference standard. Ex vivo 
19F spin density weighted imaging was also performed for all kidneys using the identical protocol 
as in vivo 19F imaging as described earlier.   
6.2.7 Data processing and statistics 
 All MRI images and signal analyses were processed with a custom-designed program 
written in Matlab (MathWorks, USA). Segmentation for different regions in healthy kidneys was 
performed manually based on 19F spin density weighted and 1H T2* weighted images. All 
statistical analyses were conducted in Origin (OriginLab, USA): paired t-tests and repeated 
measures ANOVA were used for hypothesis testing as indicated. 
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6.3 Results 
6.3.1 1H and 19F MRI of healthy kidneys 
                          
Figure 6.1 In vivo 1H and 19F images of healthy kidneys. (a & b) Representative T1-weighted and 
T2*-weighted 1H MRI of mouse kidneys in the transverse plane. (c & d) Representative spin 
density weighted and T1-weighted 19F MRI of mouse kidneys in the transverse plane. Slice 
planning is identical for 1H and 19F images and kidneys were zoomed in for better visualization. 
(C: cortex, CM: cortico-medullary junction, M: medulla, REF: external reference standard). 
 Representative 1H T1-weighted, 1H T2*-weighted, 19F spin density weighted, and 19F T1-
weighted images are shown in Figure 6.1. Contrast between the renal cortex and medulla could 
be visualized in all images. The high rate of oxygen consumption under physiological conditions 
further reduced the signal intensity at the region of the cortico-medullary junction in 1H T2*-
weighted images. It is notable that the 1H T2*-weighted image (i.e., BOLD) could not accurately 
depict the relative oxygenation at the renal medulla because most of the blood volume in this 
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region is contributed by large blood vessels, which do not create a detectable field 
inhomogeneity at the microscopic level, a necessary condition for BOLD signal imaging (42-43). 
19F spin density weighted images directly represented the relative perfusion within different 
regions of the kidneys. Specifically, 19F signal intensity decreased from the cortex to the cortico-
medullary junction and increased again at the medulla. In the inner portion of kidney where both 
medullary microvasculature and major renal artery/vein are present, relatively higher 19F signal 
was detected that correlated directly with local blood concentration. Finally, in 19F T1-weighted 
images, 19F signal intensity throughout the entire kidney was affected by the incomplete 
magnetization recovery. However, it is evident that the signal intensity at the renal medulla was 
further suppressed because of the lower oxygenation and longer 19F T1 in this region.   
      
Figure 6.2 19F MRI determined functional mapping and quantification in healthy kidneys. (a-b) 
Representative quantitative renal blood volume and oxygen tension mapping generated from 19F 
MRI of healthy kidneys. (c) Representative 1H T2* mapping of healthy kidneys. (d-f) 
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Quantification of functional indexes in different anatomical regions. Data are presented as mean 
≤ std. (C-M: cortico-medullary, *: p<0.05). 
6.3.2 Quantitative blood volume and oxygenation mapping in healthy kidneys 
 Heterogeneous distribution of renal blood volume and intrarenal oxygenation was 
confirmed in the quantitative parametric mapping of 1H T2*, RBV and pO2 as illustrated in 
Figure 6.2 (a-c). Absolute quantification of these functional indexes in different regions of 
kidneys is summarized in Figure 6.2 (d-f). Specifically, with 1H BOLD MRI, both the renal 
cortex and medulla exhibited significantly longer 1H T2*, suggesting higher tissue oxygenation, 
than did the cortico-medullary junction. This inaccurate BOLD readout of high oxygenation in 
the hypoxic inner medulla has previously been recognized as a technical limitations of BOLD 
MRI in the kidney (43).  
 19F MRI of renal blood volume revealed inhomogeneous blood supply to different 
anatomical regions of the kidney.  To wit, the measured renal blood volumes (in units of volume 
fraction per voxel or tissue weight) were: 19 ≤ 2 % in the cortex, 13 ≤ 2 % in the cortico-
medullary junction and 33 ≤ 5% in the medulla, respectively (p<0.05, for all different regions). 
The vascular pattern detected with 19F MRI is consistent with previous studies that have 
employed ex vivo micro CT (44). With the use of the measured ex vivo calibration curve relating 
19F R1 and oxygen tension: 
1
21( ) 0.0032 ( ) 0.72R s pO mmHg− = × + ,    [5] 
oxygen tension mappings were acquired under conditions of ventilation with pure oxygen. The 
cortical pO2 (361≤ 67 mmHg) was significantly higher than that in the cortico-medullary 
junction (138 ≤ 66 mmHg) or medulla (30 ≤ 20 mmHg) (p<0.05, for comparison among all three 
regions).  
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Figure 6.3 Representative 1H T2*-weighted image, 19F spin density weighted image and pO2 
mapping in contralateral and injured kidneys. The inserted panel in (f) represents the 19F 
oxygenation mapping during ischemia. White arrow points to the cortico-medullary junction and 
the white cross identifies the renal medulla. 
6.3.3 1H and 19F MRI of kidneys after ischemia-reperfusion AKI 
 Figure 6.3 shows representative 1H T2*-weighted images,19F spin density weighted 
images and 19F pO2 mapping of injured and contralateral kidneys. At 24 hours after ischemia-
reperfusion, 19F MRI revealed a complete recovery of 19F signal intensity (reflecting restoration 
of blood volume), pO2 and 1H T2* in the cortex region of injured kidneys (Figure 6.4a-c). In the 
cortico-medullary junction of injured kidneys, 19F signal intensity decreased approximately 25% 
(p < 0.05) and 1H T2* increased approximately 70% (p<0.01), which is likely a consequence of 
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edema and thrombosis (Figure 6.4a&c). In the renal medulla region, 19F and BOLD MRI 
detected 71% higher 19F signal intensity (p<0.01) and 40% lower 1H T2* value (p<0.05) in the 
injured kidneys as compared with contralateral kidneys, which may be associated with vascular 
leakage and hemorrhage-induced intrarenal retention of PFC NPs (Figure 6.4a&c). As for the 
intrarenal oxygenation defect, even though we did observe complete desaturation during 
ischemia (Figure 6.3f, insert), at 24 hours after transient ischemia-reperfusion, 19F MRI revealed 
that intrarenal oxygenation had recovered to normal level (Figure 6.4b). 
 
Figure 6.4 Absolute quantification of 19F signal intensity (a), pO2 (b) and 1H T2* (c) in different 
anatomical regions of both contralateral and injured kidneys at 24 hours after injury. Data are 
presented as mean ≤ std. (*: p<0.05 and **: p<0.01). 
6.3.4 Histology and fluorescence image 
 Endothelial staining with FITC-lectin demonstrated the reduced perfused micro-blood 
vessel density at the cortico-medullary junction (Figure 6.5a). Fluorescence microscopy of PFC 
NP confirmed the accumulation of PFC NP within the renal medulla in comparison to the 
uninjured contralateral kidneys (Figure 6.5b). By co-registering the FITC-lectin endothelial 
staining with the fluorescent PFC NP (Figure 6.5c), we observed that PFC NP accumulated 
within extravascular spaces in injured kidneys, suggesting that the high PFC NP concentration at 
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the renal medulla could be attributed to the vascular leakage expected under conditions of severe 
endothelial injury. H&E staining revealed extensive tissue damage and necrosis at the cortico-
medullary junction and in the medulla regions of injured kidneys (Figure 6). 
 
Figure 6.5 Fluorescence image of injured and contralateral kidneys. (a) Top row: overview 
fluorescence image of FITC-lectin for visualizing perfused blood vessels in contralateral and 
injured kidneys. Bottom row: zoomed-in view of FITC-lectin fluorescence image in the cortico-
medullary junction. (b) Top row: overview fluorescence image of PFC NP in contralateral and 
injured kidneys. Bottom row: zoomed-in view of PFC NP fluorescence image in the renal 
medulla. (c & d) Merged FITC-lectin and PFC NP fluorescence image of renal medulla 
confirmed that PFC NP leaked out from blood vessels and accumulated in the extravascular 
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space of injured kidneys as indicated by white arrows. (Red: PFC NP, Blue: DAPI, Green: FITC-
lectin).  
      
Figure 6.6 H&E staining of contralateral and injured kidneys. In both sub-figures, the top left 
panel is an overview of the kidney tissue and the other three panels are the high resolution 
pictures in different anatomical regions as indicated by dark arrows. H&E staining revealed 
extensive tissue damage and necrosis in the cortico-medullary junction and in the medulla (C: 
cortex, CM: cortico-medullary junction, M: medulla).  
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6.3.5 Treatment effect of PPACK NPs evaluated with 19F MRI 
 At 3-hour after reperfusion, composite 1H/19F images (Figure 6.7a&b) showed less 19F 
signal (color coded) emanating from trapped NPs in an injured kidney treated with therapeutic 
PPACK PFC NPs versus an injured kidney treated with plain PFC NPs (mostly concentrated at 
the renal medulla region). 19F spectroscopic quantification (Figure 6.7c) confirmed a higher 
number of trapped blood pool NPs, reflecting intrarenal coagulation, in I/R injured kidneys than 
that in contralateral uninjured kidneys of the same mice. Among I/R injured kidneys, however, 
substantially fewer NPs were detected in those treated with PPACK NPs reflecting its positive 
effect on inhibiting intrarenal coagulation. 
                                     
Figure 6.7 Ev vivo 19F image and quantification for retained PFC NP in ischemia-reperfusion 
injured kidneys with PPACK NPs and plain NPs pre-treatment. *, p<0.05 compared to 
contralateral uninjured kidneys; †, p< 0.05 compared to plain NP treated kidneys.  
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6.4  Discussion 
 Renal endothelial damage is a primary pathology of AKI. It leads to persistent 
inflammation and coagulation that hampers effective oxygen delivery, resulting in sustained 
injury to tubular cells even after the resumption of renal blood flow in the “extension phase” of 
AKI (45). The extent of non-perfusion is more severe in the renal medulla and cortico-medullary 
junction than in the cortex (33,46-47). Unfortunately, the interplay between inflammation and 
coagulation in AKI remains incompletely understood, due in part to the lack of appropriate 
multiparametric approaches for accurate staging of the disease process in vivo that might 
contribute to more accurate risk assessment and prognostication (48). 
 To that end, in the present study we have developed a new 19F MRI approach for 
functional kidney imaging that takes advantage of the quantifiable properties of circulating PFC 
NP. As an initial proof of concept, we have demonstrated the feasibility of combining spin 
density weighted and T1-weighted 19F images of circulating PFC NP for quantification of renal 
blood volume and oxygenation. We further demonstrated that by integrating parametric 
mappings generated from 19F MRI and conventional BOLD MRI, a more comprehensive 
diagnostic matrix for evaluating renal function and physiology is possible. The diagnostic 
capability of the proposed multi-function imaging method was evaluated in an experimental 
renal ischemia-reperfusion model of AKI. In this animal model, 19F MRI clearly delineated the 
anticipated medullary vascular leakage as a pathophysiological consequence of severe 
endothelial damage. Moreover, 19F MRI successfully defined the expected reduced blood volume 
at the cortico-medullary junction, indicating vessel occlusion as evidenced by lower density of 
perfused blood vessels detected with fluorescence imaging. Finally, the reduced blood volume 
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was associated with increased regional 1H T2* in the cortico-medullary junction as revealed by 
BOLD MRI.  
 These clinically translatable renal imaging techniques should expand the armamentarium 
for functional renal imaging in patients with existing or new onset kidney disease. The use of 
traditional functional imaging schemes, such as iodine contrast based CT and Gd based MRI, are 
significantly restricted in patients with renal insufficiency (11). Indeed, the use of such contrast 
media accounts for 10% of hospital acquired renal failure in the United States (13,20). 
Circulating PFC NP may offer a safer contrast agent for functional kidney imaging for several 
reasons. Firstly, PFC NP has been clinically approved as a blood substitute for decades, and to 
date no renal toxicity has been reported, owing in part to clearance through liver and lung portals 
instead of renal filtration. Therefore, intravenous PFC NPs are not expected to exert additional 
toxic strain on kidneys. Secondly, the unique 19F signal emanating from the PFC moieties in the 
core of the nanoparticle can be detected readily with 19F MRI. As compared to other imaging 
nuclei, 19F exhibits a high gyromagnetic ratio, and generates comparable magnetization to 1H 
nuclei in an external magnetic field. We anticipate that fully optimized imaging protocols would 
enable the entire procedure of 19F functional kidney imaging to be conducted within a clinically 
relevant time frame (<30 minutes in the present study). Thirdly, non-invasive estimates of 
intrarenal oxygen tension can be derived from 19F R1, because 19F R1 is linearly responsive to 
local oxygen tension over a wide range of values, and the oxygen exchange between blood and 
PFC occurs by free diffusion on a millisecond time scale (49). 
 Our non-invasive measurement of renal blood volume and oxygenation is consistent with 
previously reported ex-vivo (44) and invasive measurements (6,50-52). Accurate delineation of 
the distribution of renal blood volume and intrarenal oxygenation is important because of its 
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unique pattern and pathophysiological implications. In healthy kidneys, both the renal artery and 
vein branch into smaller blood vessels to perfuse the renal cortex, which is critical for 
maintaining a physiological glomerular filtration rate (GFR). It is notable that only a small 
portion of renal blood flow supports the capillary beds of the collecting ducts at the cortico-
medullary junction and medulla. Despite this marginal blood supply, the epithelial cells of the 
collecting duct still must function at a high metabolic level to support the functioning of various 
ion channels for urine concentration, and thus must operate at the hypoxic margin even under 
physiological conditions, as evidenced by the steep oxygenation gradient from renal cortex to 
medulla. Accordingly, the use of noninvasive 19F MRI to depict the inhomogeneous blood 
volume distribution and oxygenation gradient within the kidney could serve as a translational 
tool for future studies of renal pathophysiology in AKI.  
 We utilized the mouse ischemia-reperfusion AKI model for evaluating the proposed19F 
functional kidney MRI techniques because endothelial damage of the renal micro-circulation is a 
key component in this model. Extensive interaction between inflammation and coagulation takes 
place in AKI (33) and the endothelial damage elicits persistent tubular epithelial dysfunction 
even after reperfusion (46), which mimics human pathophysiology. Because of the unique 
vascular geometry found in the kidney, coagulation is most severe at the cortico-medullary 
junction and the medulla region (53). Persistent ischemia here will disturb normal fluid filtration 
and re-absorption, leading to worsening renal dysfunction and/or failure (54). Our 19F MRI 
results together with histological assessment and BOLD MRI confirmed the micro blood vessel 
non-perfusion in this region. Additionally, it has been observed that acute ischemic/hypoxic 
injury disrupts the normal blood vessel barrier, resulting in intrarenal hemorrhage and vascular 
leakage (55). PFC NPs, with a size of 250 nm, under normal circumstances function mostly as an 
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intravascular agent that does not permeate the physiological vascular barrier. However, in injured 
kidneys, a substantial accumulation of PFC NP was observed within the renal medulla in 
extravascular spaces as a consequence of severe endothelial damage. The comprehensive 
functional evaluation with 19F MRI, BOLD, and fluorescence imaging offers an alternative 
approach for examining vascular barrier disruption in vivo, as we have shown previously for 
advanced atherosclerosis (56). This technique exhibits practical translational advantages over 
conventional optical imaging (e.g., Evans blue dye) that is not clinically utile (55). Finally, the 
measured improvement of renal oxygenation imaged after 24 hours of reperfusion in this model 
indicates potential utility for following kidney damage after AKI and quantifying its responses to 
therapeutic interventions. 
 Although PPACK is a potent thrombin-inhibitor with an excellent safety profile (LD50 > 
50 mg/Kg), it has little in vivo effect because of the short elimination half-life (~3 minutes) (57). 
Conjugating PPACK to PFC NPs extended the drug elimination half-life to several hours. In 
addition, the deposited PPACK NPs on the clot surface manifested prolonged anticoagulation 
activity even after the systematic effect was diminished (37). Here we demonstrated PPACK 
PFC NPs effectively inhibit coagulation in AKI in small quantities, as evidenced by lesser 
accumulation of particles trapped by the clotting process, which suggests a new strategy for 
treating and evaluating kidney endothelial damage with thrombin targeted 19F MRI. 
 With respect to limitations of 19F functional renal imaging, because PFC NP that generate 
the 19F signal for MRI are present in circulating blood, certain flow effects could distort the 
quantitative readout of perfusion metrics. Also, at higher field strengths, paramagnetic 
deoxygenated hemoglobin generates strong local field inhomogeneities that could significantly 
reduce the signal to noise ratio of 19F MRI in the kidney. To mitigate this effect, quantitative 
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mapping of renal blood volume and oxygenation were performed only when mice were breathing 
pure oxygen. Further modifications of the imaging pulse sequences might be considered in the 
future to enable functional 19F kidney MRI under normoxic conditions. Finally, the limited 
temporal resolution of 19F MRI currently poses an obstacle for capturing the first pass of the 
contrast agent through the renal circulation. Therefore, certain dynamic parameters such as 
transient time and renal blood flow rate cannot be determined from these 19F MRI measurements. 
Again, optimizations in pulse sequence and RF coil design and performance could ultimately 
enhance detection sensitivity and enable applications that require higher temporal resolution.  
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7 Conclusion 
 In this dissertation, we first revisited the general background of molecular and functional 
imaging via MRI with a special focus on 19F MRI of PFC NP based contrast agents. We 
performed a thorough examination, both theoretically and experimentally, of the NMR/MRI 
properties of PFC NP, including chemical shifts, J-coupling and J-modulation, oxygenation and 
paramagnetic relaxation enhancement of 19F nuclear spins through their interaction with Gd 
chelates. Regarding the fundamental MR engineering for in vivo 19F MRI of PFC NP, we 
developed a generalized strategy for designing 1H/19F dual frequency RF coils, which laid the 
groundwork for subsequent 19F MR pulse sequence development and preclinical applications. 
Based on an understanding of the NMR physics of 19F MRI of PFC NP, we developed two novel 
functional imaging techniques for: (1) noninvasive measurement of the oxygenation of flowing 
blood; and (2) multi-parametric functional imaging for evaluating the renal microcirculation and 
its pathological changes in standard models of acute renal ischemic injury.   
7.1 Summary of major findings 
 In Chapter 2, we used the coupled-resonator model to develop a single-input dual 
frequency strategy for building birdcage and saddle coils that function at both 1H and 19F 
frequencies on a 4.7 T MRI scanner. The excellent matching properties and the homogeneity of 
B1 field were confirmed by S11 and S21 test measurements and by in vivo imaging in the 
C57BL/6 mouse. To enhance sensitivity, we integrated an actively decoupled surface coil with 
the dual frequency volume coils and increased the local SNR by 10 fold. As the structure of the 
volume coil was preserved, the sensitivity profile of the new dual frequency RF coils was 
essentially identical at 1H and 19F resonant frequencies. 
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 In Chapter 3, we calculated the relationship between J-modulation of a representative 
PFC molecule (PFOB) and the imaging RF pulse bandwidth. Density matrix and experimental 
analyses suggested that narrow band RF pulses could suppress the J-modulation in 19F spin echo 
imaging. By employing Bloch equation modeling, we also simulated the oxygenation effect on 
19F quantification. We showed that absolute  quantification of the 19F MR signals from PFC NP 
is insensitive to the oxygen concentration as long as TR> 3* T1, and moreover that shorter TE 
always facilitate the achievement of greater 19F sensitivities even in the presence of the J-
coupling effect. In the end, we took advantage of the multiple and widely separated chemical 
shifts of PFC NP to implement a “multi-chromatic” 19F MRI technique that is capable of imaging 
at least five different PFC components in the same phantom using ultra narrow band RF pulses. 
The feasibility of “multi-chromatic” 19F was demonstrated in vitro in cellular imaging studies 
and in vivo with 19F MRI of a mouse leg.  
 In Chapter 4, we demonstrated that the 19F signal strength emanating from PFC NP could 
be enhanced by incorporating a large number of paramagnetic moieties (Gd) into a monolayer 
lipid membrane surrounding a 19F core. Our results showed that 19F T1
 
shortening can be 
attributed to the Brownian motion of core PFC molecules inside the NP.  An explicit expression 
for the relaxation enhancement was derived to describe the physical mechanisms that lead to 
enhanced longitudinal relaxation of 19F nuclear spins. The theoretical description was confirmed 
experimentally by field-dependent T1 measurements. The interaction between 19F nuclear spins 
and Gd electron spins was observed to be highly dependent on the separation distance between 
them, which results in a “relaxation switch” phenomenon, which could be used to detect cellular 
processing of the contrast agent by macrophage endosomal activation. Specifically, after 
paramagnetic PFC NP was internalized by macrophages through endocytosis, endosomal 
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processing stripped the lipid surfactant layer containing the Gd away from the PFC core, 
resulting in the separation of 19F and Gd atoms beyond the point where the Gd could exert an 
outer sphere influence on 19F relaxation, leading rapidly to complete elimination of the 
exogenous relaxation enhancement of 19F T1. 
 In Chapter 5, we developed a novel Blood flow-Enhanced-Saturation-Recovery (BESR) 
sequence, which allowed rapid in vivo T1 measurement of blood for both 1H and 19F nuclei. 
BESR sequence was achieved by combining homogeneous spin preparation and time-of-flight 
image acquisition, which served to preserve both efficient imaging and SNR for 19F imaging of 
circulating PFC NP. The consistency and accuracy of the BESR sequence for measuring T1 of 
blood was validated experimentally. After confirming the linear response of 19F R1 to increasing 
oxygen tension in both salt solutions and blood samples in vitro, we demonstrated the utility of 
the BESR sequence for quantification of oxygen tension within the mouse left and right 
ventricles under both normoxic and hyperoxic conditions.  
 In Chapter 6, we developed a unique sensor-reporter approach for functional kidney 
imaging that employs circulating PFC NP and 19F MRI. Our noninvasive in vivo 19F MRI 
technique generated quantitative readouts of renal blood volume and intrarenal oxygenation to 
describe the renal circulation in healthy mouse kidneys. In a mouse model of acute kidney injury 
(AKI, warm ischemia-reperfusion), we sensitively delineated renal vascular damage and 
recovery with the use of the proposed 19F functional MRI strategy, in conjunction with 1H Blood-
Oxygenation-Level-Dependant (BOLD) MRI. In the cortico-medullary junction region, we 
reported a 25% lower 19F signal (p<0.05) and 70% longer 1H T2* (p<0.01) in injured kidneys 
as compared with the contralateral kidneys by 24 hours after initial ischemia-reperfusion injury. 
We also detected 71% greater 19F signal (p<0.01) and 40% lower 1H T2* (p<0.05) in the renal 
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medulla region of injured kidneys compared to contralateral kidneys. Moreover, with the use of 
ex vivo 19F MRI, we determined that PPACK PFC NPs effectively inhibit microvascular 
coagulation in AKI, as evidenced by reduced accumulation of particles trapped by the ongoing 
clotting process, which suggests a new strategy for treating and evaluating kidney endothelial 
damage with thrombin targeted 19F MRI. 
7.2 Future works 
7.2.1 Applications of “relaxation switch” 
 The “Relaxation switch” phenomenon first reported in this work could serve as a new 
approach to evaluate the uptake and processing of PFC NP by myriad tissues. By measuring 19F 
T1 of paramagnetic PFC NP, one might dynamically track the intracellular processing and 
disposition of these particles. In many applications, it is important but difficult to identify 
whether PFC NPs accumulate in intracellular environments or only are trapped locally in the 
extracellular matrix: if processed rapidly intracellularly, the “relaxation switch” approach could 
offer more direct insights into such cell processing mechanisms. 
7.2.2 Tracking multiple biomarkers in vivo 
 The multi-chromatic 19F technique could be readily applied to several clinically relevant 
disease models to elucidate the presence of multitudinous biomarkers. For example, in the 
coagulation process, thrombin cleaves fibrinogen to fibrin, which deposit in thrombi along with 
platelets that are activated by thrombin. Many thrombin-inhibiting drugs, including the PPACK 
PFC NP that was investigated in this dissertation, diminish the coagulation process by actively 
binding to and irreversibly inactivating thrombin. Therefore, to better evaluate the treatment 
effect and investigate the clotting pathology, it might be helpful to quantify both the presence of 
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the anti-thrombin drugs and the molecular target itself, fibrin, in the clot, which would facilitate 
pharmacokinetic and pharmacodynamic assessment over time. Such applications could be 
realized in a non-invasive manner by combing the multi-chromatic 19F imaging technique with 
fibrin-targeted PFC NPs and anti-thrombin PFC NPs which are already available. 
7.2.3 Relation between cellular pO2, tissue pO2 and vascular pO2 
 Because of the relatively large size of PFC NPs, which remain intravascular, the 
oxygenation measurements reported in this dissertation actually represent the pO2 in micro and 
macro vasculature. However, because of the limited diffusivity of O2 in biological tissues, the 
pO2 in soft tissues remote from the flowing blood supply could be dramatically different from 
vascular oxygen levels.  Likewise, local interstitial pO2 also would exceed intracellular pO2. For 
example, in many tumor models, most cancer cells might function under highly hypoxic 
environment especially in under-perfused regions. However, many observations have suggested 
that intravascular pO2 in tumor tissue might be even higher than in normal microvasculature; 
possibly due to the special arrangement of blood vessels in solid tumors that hinders effective 
diffusion of O2 from blood to hypoxic tumor tissues. It is possible then by using different PFC 
NPs to label tumor cells themselves, tumor vasculature, and extracellular tissue space, we could 
fully delineate the pO2 differences in various compartments by imaging each PFC NP component 
individually. 
7.2.4 Dynamic monitor of functional change in AKI kidneys 
 We have demonstrated the feasibility of using 19F MRI to evaluate endothelial damage in 
AKI kidneys. As a next step, it would be germane to perform follow-up imaging studies at 
different time points after the initial surgery to fully map out the recovery process. Also, 
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investigation of more severe extents of injury by extending the ischemia time could be useful for 
developing methods more predictive of ultimate recovery or failure. 
7.2.5  In vivo evaluation of treatment effect of PPACK NP for AKI 
 We also demonstrated in vivo 19F functional imaging of ischemia-reperfusion injured 
kidney and ex vivo 19F imaging for evaluating the treatment effect of PPACK NP on injured 
kidneys. Going forward, it would be critical to perform in vivo 19F MRI to evaluate treatment 
effects in this disease model. In particular, delivering one PFC NP as drug delivery vehicle and a 
different type of PFC NP as a contrast agent could utilize multi-chromatic 19F MRI techniques to 
generate both a parametric mapping of renal microcirculation and quantitative readout of the 
concentration of the anti-thrombosis drug. 
7.2.6 Combining 19F oxygenation and 1H phase contrast imaging for oxygen consumption 
measurements 
 The new 19F BESR sequence might find other uses for measuring blood oxygenation in 
large blood vessels. For example, in combination with 19F oxygenation mapping, 1H phase 
contrast angiography could provide a quantitative estimate of blood velocity. Together, the pO2 
and blood flow information would allow the calculation of tissue oxygen consumption, which is 
an important metabolic index of organ viability and functionality. This technique could be tested 
in brain, lung, kidneys, heart and other organs for proof of concept, under normoxic and 
ischemic conditions. 
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7.2.7 Combining VCAM targeted scheme with PPACK NP for targeted imaging and 
treatment 
 It is known that the interplay between inflammation and coagulation plays a pivotal role 
in the persistence of renal endothelial damage in AKI. By functionalizing anti-thrombin PPACK 
NP with an anti-VCAM-1 peptide, we might enhance the focal accumulation of therapeutic 
PPACK NPs in inflammatory vessels that manifest upregulated VCAM-1 as a part of the 
inflammatory process. The VCAM-1 targeted PPACK NP might be especially beneficial for 
therapy of evolving AKI, because a large component of the inflammatory responses ensues after 
reperfusion. Again, ex vivo 19F quantification and in vivo functional 19F imaging techniques 
might prove useful for following the treatment effect of this new nanodrug approach. 
